2019 ESC Guidelines for themanagement of patients with supraventricular tachycardia

Ablation; Arrhythmia; Atrioventricular; Flutter; Focal; Guidelines; Junctional; Macrore-entrant; Nodal; Pre-excitation; Re-entrant; Supraventricular; Tachycardia; Article; Ebstein anomaly; Europe; Fallot tetralogy; Fontan procedure; QRS interval; Wolff Parkinson White syndrome

Disciplines :

Cardiovascular & respiratory systems

Author, co-author :

Brugada, J.; Cardiology Department, Hospital Clinic, Pediatric Arrhythmia Unit, Hospital Sant Joan de Déu, University of Barcelona, Spain

Katritsis, D. G.; Department of Cardiology, Hygeia Hospital, E. Stavrou 4, Athens, 15123, Greece

Arbelo, E.; Spain, Arrhythmia Unit, Cardiovascular Institute, Hospital Clinic de Barcelona, Universitat de Barcelona, Spain, Cardiovascular Institute, Hospital Clínic, Universitat de Barcelona, Barcelona, Spain, Institut d'Investigació August Pi i Sunyer (IDIBAPS), Centro de Investigación Biomédica en Red de Enfermedades, Barcelona, Spain

Arribas, F.; Spain, Department of Cardiology, Hospital 12 de Octubre, Madrid, Spain

Bax, J. J.; Netherlands, Leiden University Medical Center, Leiden, Netherlands

Blomstrom-Lundqvist, C.; Sweden, Department of Medical Science and Cardiology, Uppsala University, Uppsala, Sweden

Calkins, H.; United States, John Hopkins Medical Institutions, Baltimore, United States

Corrado, D.; Italy

Deftereos, S. G.; Greece, 2nd Department of Cardioloy, National and Kapodistrian University of Athens, Athens, Greece

Diller, G.-P.; Germany, University Hospital Muenster, Muenster, Germany

More authors (104 more)

Language :

English

Title :

2019 ESC Guidelines for themanagement of patients with supraventricular tachycardia

Publication date :

2020

Journal title :

European Heart Journal

ISSN :

0195-668X

eISSN :

1522-9645

Publisher :

Oxford University Press

Volume :

Issue :

Pages :

655-720

Peer reviewed :

Peer Reviewed verified by ORBi

Funders :

ESC - European Society of Cardiology

Available on ORBi :

since 19 January 2021

Statistics

Number of views

1391 (1 by ULiège)

Number of downloads

1684 (1 by ULiège)

More statistics

Scopus citations^®

760

Scopus citations^®
without self-citations

660

OpenCitations

376

OpenAlex citations

889

Bibliography

Blomström-Lundqvist C, Scheinman MM, Aliot EM, Alpert JS, Calkins H, Camm AJ, Campbell WB, Haines DE, Kuck KH, Lerman BB, Miller DD, Shaeffer CW, Stevenson WG, Tomaselli GF. ACC/AHA/ESC guidelines for the management of patients with supraventricular arrhythmias-executive summary: A report of the American college of cardiology/American heart association task force on practice guidelines and the European society of cardiology committee for practice guidelines (writing committee to develop guidelines for the management of patients with supraventricular arrhythmias) developed in collaboration with NASPE-Heart Rhythm Society. J Am Coll Cardiol 2003; 42:1493-1531.
Page RL, Joglar JA, Caldwell MA, Calkins H, Conti JB, Deal BJ, Estes NAM, Field ME, Goldberger ZD, Hammill SC, Indik JH, Lindsay BD, Olshansky B, Russo AM, Shen W-K, Tracy CM, Al-Khatib SM. 2015 ACC/AHA/HRS guideline for the management of adult patients with supraventricular tachycardia: Executive summary: A report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society. J Am Coll Cardiol 2016; 67:1575-1623.
Katritsis DG, Boriani G, Cosio FG, Hindricks G, Jais P, Josephson ME, Keegan R, Kim Y-H, Knight BP, Kuck K-H, Lane DA, Lip GYH, Malmborg H, Oral H, Pappone C, Themistoclakis S, Wood KA, Blomström-Lundqvist C. European Heart Rhythm Association (EHRA) consensus document on the management of supraventricular arrhythmias, endorsed by Heart Rhythm Society (HRS), Asia-Pacific Heart Rhythm Society (APHRS), and Sociedad Latinoamericana de Estimulacion Cardiaca y Electrofisiologia (SOLAECE). Eur Heart J 2018; 39:1442-1445.
Kirchhof P, Benussi S, Kotecha D, Ahlsson A, Atar D, Casadei B, Castella M, Diener H-C, Heidbuchel H, Hendriks J, Hindricks G, Manolis AS, Oldgren J, Popescu BA, Schotten U, Van Putte B, Vardas P, Agewall S, Camm J, Baron Esquivias G, Budts W, Carerj S, Casselman F, Coca A, De Caterina R, Deftereos S, Dobrev D, Ferro JM, Filippatos G, Fitzsimons D, Gorenek B, Guenoun M, Hohnloser SH, Kolh P, Lip GYH, Manolis A, McMurray J, Ponikowski P, Rosenhek R, Ruschitzka F, Savelieva I, Sharma S, Suwalski P, Tamargo JL, Taylor CJ, Van Gelder IC, Voors AA, Windecker S, Zamorano JL, Zeppenfeld K. 2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS. Eur Heart J 2016; 37:2893-2962.
Calkins H, Hindricks G, Cappato R, Kim YH, Saad EB, Aguinaga L, Akar JG, Badhwar V, Brugada J, Camm J, Chen PS, Chen SA, Chung MK, Nielsen JC, Curtis AB, Davies DW, Day JD, d'Avila A, de Groot N, Di Biase L, Duytschaever M, Edgerton JR, Ellenbogen KA, Ellinor PT, Ernst S, Fenelon G, Gerstenfeld EP, Haines DE, Haissaguerre M, Helm RH, Hylek E, Jackman WM, Jalife J, Kalman JM, Kautzner J, Kottkamp H, Kuck KH, Kumagai K, Lee R, Lewalter T, Lindsay BD, Macle L, Mansour M, Marchlinski FE, Michaud GF, Nakagawa H, Natale A, Nattel S, Okumura K, Packer D, Pokushalov E, Reynolds MR, Sanders P, Scanavacca M, Schilling R, Tondo C, Tsao HM, Verma A, Wilber DJ, Yamane T. 2017 HRS/EHRA/ECAS/APHRS/SOLAECE expert consensus statement on catheter and surgical ablation of atrial fibrillation: Executive summary. Europace 2018; 20:157-208.
Mairesse GH, Moran P, Van Gelder IC, Elsner C, Rosenqvist M, Mant J, Banerjee A, Gorenek B, Brachmann J, Varma N, Glotz de Lima G, Kalman J, Claes N, Lobban T, Lane D, Lip GYH, Boriani G; ESC Scientific Document Group. Screening for atrial fibrillation: A European Heart Rhythm Association (EHRA) consensus document endorsed by the Heart Rhythm Society (HRS), Asia Pacific Heart Rhythm Society (APHRS), and Sociedad Latinoamericana de Estimulacion Cardiaca y Electrofisiologia (SOLAECE). Europace 2017; 19:1589-1623.
Lip GYH, Collet JP, Haude M, Huber K. Management of antithrombotic therapy in AF patients presenting with ACS and/or undergoing PCI: A summary of the Joint Consensus Document of the European Heart Rhythm Association (EHRA), European Society of Cardiology Working Group on Thrombosis, European Association of Percutaneous Cardiovascular Interventions (EAPCI) and European Association of Acute Cardiac Care (ACCA) endorsed by the Heart Rhythm Society (HRS), Asia-Pacific Heart Rhythm Society (APHRS), Latin America Heart Rhythm Society (LAHRS), and Cardiac Arrhythmia Society of Southern Africa (CASSA). Eur Heart J 2018; 39:2847-2850.
Wit AL, Wellens HJ, Josephson ME. Electrophysiological foundations of cardiac arrhythmias. 1st ed. Minneapolis: Cardiotext Publishing; 2017.
Orejarena LA, Vidaillet H, DeStefano F, Nordstrom DL, Vierkant RA, Smith PN, Hayes JJ. Paroxysmal supraventricular tachycardia in the general population. J Am Coll Cardiol 1998; 31:150-157.
Wu M-H, Chen H-C, Kao F-Y, Huang S-K. Postnatal cumulative incidence of supraventricular tachycardia in a general pediatric population: A national birth cohort database study. Heart Rhythm 2016; 13:2070-2075.
García-Fernandez FJ, Ibañez Criado JL, Quesada Dorador A; collaborators of the Spanish Catheter Ablation Registry; REGISTRY COLLABORATORS. Spanish Catheter Ablation Registry. 17th Official Report of the Spanish Society of Cardiology Working Group on Electrophysiology and Arrhythmias (2017). Rev Esp Cardiol (Engl Ed) 2018; 71:941-951.
Hosseini SM, Rozen G, Saleh A, Vaid J, Biton Y, Moazzami K, Heist EK, Mansour MC, Kaadan MI, Vangel M, Ruskin JN. Catheter ablation for cardiac arrhythmias: Utilization and in-hospital complications, 2000 to 2013. JACC Clin Electrophysiol 2017; 3:1240-1248.
Holmqvist F, Kesek M, Englund A, Blomström-Lundqvist C, Karlsson LO, Kennebäck G, Poçi D, Samo-Ayou R, Sigurjonsdottir R, Ringborn M, Herczku C, Carlson J, Fengsrud E, Tabrizi F, Höglund N, Lönnerholm S, Kongstad O, Jönsson A, Insulander P. A decade of catheter ablation of cardiac arrhythmias in Sweden: Ablation practices and outcomes. Eur Heart J 2019; 40:820-830.
Porter MJ, Morton JB, Denman R, Lin AC, Tierney S, Santucci PA, Cai JJ, Madsen N, Wilber DJ. Influence of age and gender on the mechanism of supraventricular tachycardia. Heart Rhythm 2004; 1:393-396.
Gonzalez-Torrecilla E, Almendral J, Arenal A, Atienza F, Atea LF, del Castillo S, Fernandez-Aviles F. Combined evaluation of bedside clinical variables and the electrocardiogram for the differential diagnosis of paroxysmal atrioventricular reciprocating tachycardias in patients without pre-excitation. J Am Coll Cardiol 2009; 53:2353-2358.
Liuba I, Jönsson A, Säfström K, Walfridsson H. Gender-related differences in patients with atrioventricular nodal reentry tachycardia. Am J Cardiol 2006; 97:384-388.
Rosano GMC, Leonardo F, Rosano GMC, De Luca F, Sarrel PM, Beale CM, Collins P. Cyclical variation in paroxysmal supraventricular tachycardia in women. Lancet 1996; 347:786-788.
Chang S-H, Kuo C-F, Chou I-J, See L-C, Yu K-H, Luo S-F, Chiou M-J, Zhang W, Doherty M, Wen M-S, Chen W-J, Yeh Y-H. Outcomes associated with paroxysmal supraventricular tachycardia during pregnancy. Circulation 2017; 135:616-618.
Krahn AD, Manfreda J, Tate RB, Mathewson FL, Cuddy T. The natural history of electrocardiographic preexcitation in men: The Manitoba Follow-up Study. Ann Intern Med 1992; 116:456-460.
Vidaillet HJJ, Pressley JC, Henke E, Harrell FEJ, German LD. Familial occurrence of accessory atrioventricular pathways (preexcitation syndrome). N Engl J Med 1987; 317:65-69.
Lu C-W, Wu M-H, Chen H-C, Kao F-Y, Huang S-K. Epidemiological profile of Wolff-Parkinson-White syndrome in a general population younger than 50 years of age in an era of radiofrequency catheter ablation. Int J Cardiol 2014; 174:530-534.
Skov MW, Rasmussen PV, Ghouse J, Hansen SM, Graff C, Olesen MS, Pietersen A, Torp-Pedersen C, Haunsø S, Køber L, Svendsen JH, Holst AG, Nielsen JB. Electrocardiographic preexcitation and risk of cardiovascular morbidity and mortality. Results from the Copenhagen ECG Study. Circ Arrhythm Electrophysiol 2017; 10:e004778.
Granada J, Uribe W, Chyou P-H, Maassen K, Vierkant R, Smith PN, Hayes J, Eaker E, Vidaillet H. Incidence and predictors of atrial flutter in the general population. J Am Coll Cardiol 2000; 36:2242-2246.
Withers KL, White J, Carolan-Rees G, Patrick H, O'Callaghan P, Murray S, Cunningham D, Wood KA, Lencioni M, Griffith M. Patient reported outcome measures for cardiac ablation procedures: A multicentre pilot to develop a new questionnaire. Europace 2014; 16:1626-1633.
Wood KA, Stewart AL, Drew BJ, Scheinman MM, Froelicher ES. Patient perception of symptoms and quality of life following ablation in patients with supraventricular tachycardia. Heart Lung 2010; 39:12-20.
White J, Withers KL, Lencioni M, Carolan-Rees G, Wilkes AR, Wood KA, Patrick H, Cunningham D, Griffith M. Cardiff cardiac ablation patient-reported outcome measure (C-CAP): Validation of a new questionnaire set for patients undergoing catheter ablation for cardiac arrhythmias in the UK. Qual Life Res 2016; 25:1571-1583.
Brachmann J, Lewalter T, Kuck KH, Andresen D, Willems S, Spitzer SG, Straube F, Schumacher B, Eckardt L, Danilovic D, Thomas D, Hochadel M, Senges J. Long-term symptom improvement and patient satisfaction following catheter ablation of supraventricular tachycardia: Insights from the German ablation registry. Eur Heart J 2017; 38:1317-1326.
Farkowski MM, Pytkowski M, Maciag A, Golicki D, Wood KA, Kowalik I, Kuteszko R, Szwed H. Gender-related differences in outcomes and resource utilization in patients undergoing radiofrequency ablation of supraventricular tachycardia: Results from Patients' Perspective on Radiofrequency Catheter Ablation of AVRT and AVNRT Study. Europace 2014; 16:1821-1827.
Feldman A, Voskoboinik A, Kumar S, Spence S, Morton JB, Kistler PM, Sparks PB, Vohra JK, Kalman JM. Predictors of acute and long-term success of slow pathway ablation for atrioventricular nodal reentrant tachycardia: A single center series of 1, 419 consecutive patients. Pacing Clin Electrophysiol 2011; 34:927-933.
Zimetbaum P, Josephson ME. Evaluation of patients with palpitations. N Engl J Med 1998; 338:1369-1373.
Page RL, Wilkinson WE, Clair WK, McCarthy EA, Pritchett EL. Asymptomatic arrhythmias in patients with symptomatic paroxysmal atrial fibrillation and paroxysmal supraventricular tachycardia. Circulation 1994; 89:224-227.
Thavendiranathan P, Bagai A, Khoo C, Dorian P, Choudhry NK. Does this patient with palpitations have a cardiac arrhythmia?. JAMA 2009; 302:2135-2143.
Leitch JW, Klein GJ, Yee R, Leather RA, Kim YH. Syncope associated with supraventricular tachycardia. An expression of tachycardia rate or vasomotor response?. Circulation 1992; 85:1064-1071.
Thiruganasambandamoorthy V, Rowe BH, Sivilotti MLA, McRae AD, Arcot K, Nemnom MJ, Huang L, Mukarram M, Krahn AD, Wells GA, Taljaard M. Duration of electrocardiographic monitoring of emergency department patients with syncope. Circulation 2019; 139:1396-1406.
Razavi M, Luria DM, Jahangir A, Hodge DO, Low PA, Shen W-K. Acute blood pressure changes after the onset of atrioventricular nodal reentrant tachycardia: A time-course analysis. J Cardiovasc Electrophysiol 2005; 16:1037-1040.
Abe H, Nagatomo T, Kobayashi H, Miura Y, Araki M, Kuroiwa A, Nakashima Y. Neurohumoral and hemodynamic mechanisms of diuresis during atrioventricular nodal reentrant tachycardia. Pacing Clin Electrophysiol 1997; 20(11):2783-2788.
Chinen S, Miura M, Tamame T, Matsuoka M, Ohki H, Sumitomo N. Life-threatening atrial tachycardia after the Senning operation in a patient with transposition of the great arteries. Heart Vessels 2012; 27:424-427.
Gürsoy S, Steurer G, Brugada J, Andries E, Brugada P. The hemodynamic mechanism of pounding in the neck in atrioventricular nodal reentrant tachycardia. N Engl J Med 1992; 327:772-774.
Contreras-Valdes FM, Josephson ME. IMAGES IN CLINICAL MEDICINE. "Frog sign" in atrioventricular nodal reentrant tachycardia. N Engl J Med 2016; 374:e17.
Lessmeier TJ, Gamperling D, Johnson-Liddon V, Fromm BS, Steinman RT, Meissner MD, Lehmann MH. Unrecognized paroxysmal supraventricular tachycardia: Potential for misdiagnosis as panic disorder. Arch Intern Med 1997; 157:537-543.
Appelboam A, Reuben A, Mann C, Gagg J, Ewings P, Barton A, Lobban T, Dayer M, Vickery J, Benger J. Postural modification to the standard Valsalva manoeuvre for emergency treatment of supraventricular tachycardias (REVERT): A randomised controlled trial. Lancet 2015; 386:1747-1753.
Wang R, Blackburn G, Desai M, Phelan D, Gillinov L, Houghtaling P, Gillinov M. Accuracy of wrist-worn heart rate monitors. JAMA Cardiol 2017; 2:104-106.
Katritsis DG, Mark DB, Gersh BJ. Revascularization in stable coronary disease: Evidence and uncertainties. Nat Rev Cardiol 2018; 15:408-419.
Michowitz Y, Tovia-Brodie O, Heusler I, Sabbag A, Rahkovich M, Shmueli H, Glick A, Belhassen B. Differentiating the QRS morphology of posterior fascicular ventricular tachycardia from right bundle branch block and left anterior hemiblock aberrancy. Circ Arrhythm Electrophysiol 2017; 10:e005074.
Katritsis DG, Josephson ME. Differential diagnosis of regular, narrow-QRS tachycardias. Heart Rhythm 2015; 12:1667-1676.
Roberts-Thomson KC, Kistler PM, Kalman JM. Focal atrial tachycardia I: Clinical features, diagnosis, mechanisms, and anatomic location. Pacing Clin Electrophysiol 2006; 29:643-652.
Katritsis DG, Becker A. The atrioventricular nodal reentrant tachycardia circuit: A proposal. Heart Rhythm 2007; 4:1354-1360.
Jaïs P, Matsuo S, Knecht S, Weerasooriya R, Hocini M, Sacher F, Wright M, Nault I, Lellouche N, Klein G, Clémenty J, Haïssaguerre M. A deductive mapping strategy for atrial tachycardia following atrial fibrillation ablation: Importance of localized reentry. J Cardiovasc Electrophysiol 2009; 20:480-491.
Green M, Heddle B, Dassen W, Wehr M, Abdollah H, Brugada P, Wellens HJ. Value of QRS alteration in determining the site of origin of narrow QRS supraventricular tachycardia. Circulation 1983; 68:368-373.
Chen SA, Tai CT, Chiang CE, Chang MS. Role of the surface electrocardiogram in the diagnosis of patients with supraventricular tachycardia. Cardiol Clin 1997; 15:539-565.
Morady F. Significance of QRS alternans during narrow QRS tachycardias. Pacing Clin Electrophysiol 1991; 14:2193-2198.
Crawford TC, Mukerji S, Good E, Chugh A, Bogun F, Pelosi F, Oral H, Morady F, Jongnarangsin K. Utility of atrial and ventricular cycle length variability in determining the mechanism of paroxysmal supraventricular tachycardia. J Cardiovasc Electrophysiol 2007; 18:698-703.
Bogossian H, Ninios I, Frommeyer G, Bandorski D, Eckardt L, Lemke B, Zarse M. U wave during supraventricular tachycardia: Simulation of a long RP tachycardia and hiding the common type AVNRT. Ann Noninvasive Electrocardiol 2015; 20:292-295.
Nagashima K, Watanabe I, Okumura Y, Kaneko Y, Sonoda K, Kogawa R, Sasaki N, Iso K, Takahashi K, Kurokawa S, Nakai T, Ohkubo K, Hirayama A. Ventriculoatrial intervals <70 ms in orthodromic atrioventricular reciprocating tachycardia. Pacing Clin Electrophysiol 2016; 39:1108-1115.
Letsas KP, Weber R, Herrera Siklody C, Mihas CC, Stockinger J, Blum T, Kalusche D, Arentz T. Electrocardiographic differentiation of common type atrioventricular nodal reentrant tachycardia from atrioventricular reciprocating tachycardia via a concealed accessory pathway. Acta Cardiologica 2010; 65:171-176.
Kalbfleisch SJ, el-Atassi R, Calkins H, Langberg JJ, Morady F. Differentiation of paroxysmal narrow QRS complex tachycardias using the 12-lead electrocardiogram. J Am Coll Cardiol 1993; 21:85-89.
Tai CT, Chen SA, Chiang CE, Lee SH, Wen ZC, Chiou CW, Ueng KC, Chen YJ, Yu WC, Chang MS. A new electrocardiographic algorithm using retrograde P waves for differentiating atrioventricular node reentrant tachycardia from atrioventricular reciprocating tachycardia mediated by concealed accessory pathway. J Am Coll Cardiol 1997; 29:394-402.
Di Toro D, Hadid C, Lopez C, Fuselli J, Luis V, Labadet C. Utility of the aVL lead in the electrocardiographic diagnosis of atrioventricular node re-entrant tachycardia. Europace 2009; 11:944-948.
Haghjoo M, Bahramali E, Sharifkazemi M, Shahrzad S, Peighambari M. Value of the aVR lead in differential diagnosis of atrioventricular nodal reentrant tachycardia. Europace 2012; 14:1624-1628.
Knight BP, Ebinger M, Oral H, Kim MH, Sticherling C, Pelosi F, Michaud GF, Strickberger SA, Morady F. Diagnostic value of tachycardia features and pacing maneuvers during paroxysmal supraventricular tachycardia. J Am Coll Cardiol 2000; 36:574-582.
Markowitz SM, Stein KM, Mittal S, Slotwtner DJ, Lerman BB. Differential effects of adenosine on focal and macroreentrant atrial tachycardia. J Cardiovasc Electrophysiol 1999; 10:489-502.
Alzand BSN, Manusama R, Gorgels APM, Wellens HJJ. An "almost wide" QRS tachycardia. Circ Arrhythm Electrophysiol 2009; 2:e1-e3.
Alzand BSN, Crijns HJ. Diagnostic criteria of broad QRS complex tachycardia: Decades of evolution. Europace 2011; 13:465-472.
Stewart RB, Bardy GH, Greene H. Wide complex tachycardia: Misdiagnosis and outcome after emergent therapy. Ann Intern Med 1986; 104:766-771.
Wellens HJJ. Ventricular tachycardia: Diagnosis of broad QRS complex tachycardia. Heart 2001; 86:579-585.
Willems S, Shenasa M, Borggrefe M, Hindricks G, Chen X, Rotman B, Kottkamp H, Haverkamp W, Breithardt G. Atrioventricular nodal reentry tachycardia: Electrophysiologic comparisons in patients with and without 2:1 infra-His block. Clin Cardiol 1993; 16:883-888.
Ranger S, Talajic M, Lemery R, Roy D, Villemaire C, Nattel S. Kinetics of usedependent ventricular conduction slowing by antiarrhythmic drugs in humans. Circulation 1991; 83:1987-1994.
Jastrzebski M, Kukla P, Czarnecka D, Kawecka-Jaszcz K. Comparison of five electrocardiographic methods for differentiation of wide QRS-complex tachycardias. Europace 2012; 14:1165-1171.
Brugada P, Brugada J, Mont L, Smeets J, Andries EW. A new approach to the differential diagnosis of a regular tachycardia with a wide QRS complex. Circulation 1991; 83:1649-1659.
Kindwall KE, Brown J, Josephson ME. Electrocardiographic criteria for ventricular tachycardia in wide complex left bundle branch block morphology tachycardias. Am J Cardiol 1988; 61:1279-1283.
Vereckei A, Duray G, Szénasi G, Altemose GT, Miller JM. New algorithm using only lead aVR for differential diagnosis of wide QRS complex tachycardia. Heart Rhythm 2008; 5:89-98.
Pava LF, Perafan P, Badiel M, Arango JJ, Mont L, Morillo CA, Brugada J. R-wave peak time at DII: A new criterion for differentiating between wide complex QRS tachycardias. Heart Rhythm 2010; 7:922-926.
Steurer G, Gursoy S, Frey B, Simonis F, Andries E, Kuck K, Brugada P. The differential diagnosis on the electrocardiogram between ventricular tachycardia and preexcited tachycardia. Clin Cardiol 1994; 17:306-308.
Jastrzebski M, Moskal P, Kukla P, Fijorek K, Kisiel R, Czarnecka D. Specificity of wide QRS complex tachycardia criteria and algorithms in patients with ventricular preexcitation. Ann Noninvasive Electrocardiol 2018; 23:e12493.
Alberca T, Almendral J, Sanz P, Almazan A, Cantalapiedra JL, Delcan JL. Evaluation of the specificity of morphological electrocardiographic criteria for the differential diagnosis of wide QRS complex tachycardia in patients with intraventricular conduction defects. Circulation 1997; 96:3527-3533.
Ceresnak SR, Liberman L, Avasarala K, Tanel R, Motonaga KS, Dubin AM. Are wide complex tachycardia algorithms applicable in children and patients with congenital heart disease?. J Electrocardiol 2010; 43:694-700.
Jastrzebski M, Kukla P, Czarnecka D, Kawecka-Jaszcz K. Specificity of the wide QRS complex tachycardia algorithms in recipients of cardiac resynchronization therapy. J Electrocardiol 2012; 45:319-326.
Lau EW, Ng GA. Comparison of the performance of three diagnostic algorithms for regular broad complex tachycardia in practical application. Pacing Clin Electrophysiol 2002; 25:822-827.
Isenhour JL, Craig S, Gibbs M, Littmann L, Rose G, Risch R. Wide-complex tachycardia: Continued evaluation of diagnostic criteria. Acad Emerg Med 2000; 7:769-773.
Baxi RP, Hart KW, Vereckei A, Miller J, Chung S, Chang W, Gottesman B, Hunt M, Culyer G, Trimarco T, Willoughby C, Suarez G, Lindsell CJ, Collins SP. Vereckei criteria as a diagnostic tool amongst emergency medicine residents to distinguish between ventricular tachycardia and supra-ventricular tachycardia with aberrancy. J Cardiol 2012; 59:307-312.
Jastrzebski M, Sasaki K, Kukla P, Fijorek K, Stec S, Czarnecka D. The ventricular tachycardia score: A novel approach to electrocardiographic diagnosis of ventricular tachycardia. Europace 2016; 18:578-584.
Yadav AV, Nazer B, Drew BJ, Miller JM, El Masry H, Groh WJ, Natale A, Marrouche N, Badhwar N, Yang Y, Scheinman MM. Utility of conventional electrocardiographic criteria in patients with idiopathic ventricular tachycardia. JACC Clin Electrophysiol 2017; 3:669-677.
Knight BP, Zivin A, Souza J, Goyal R, Man KC, Strickberger A, Morady F. Use of adenosine in patients hospitalized in a university medical center. Am J Med 1998; 105:275-280.
Jolobe OMP. Caveats in preexcitation-related atrial fibrillation. Am J Emerg Med 2010; 28:252-253.
Murman DH, McDonald AJ, Pelletier AJ, Camargo CA. U.S. Emergency Department Visits for Supraventricular Tachycardia, 1993-2003. Acad Emerg Med 2007; 14(6):578-581.
Roth A, Elkayam I, Shapira I, Sander J, Malov N, Kehati M, Golovner M. Effectiveness of prehospital synchronous direct-current cardioversion for supraventricular tachyarrhythmias causing unstable hemodynamic states. Am J Cardiol 2003; 91:489-491.
Wittwer MR, Rajendran S, Kealley J, Arstall MA. A South Australian registry of biphasic cardioversions of atrial arrhythmias: Efficacy and predictors of success. Heart Lung Circ 2015; 24:342-347.
Reisinger J, Gstrein C, Winter T, Zeindlhofer E, Höllinger K, Mori M, Schiller A, Winter A, Geiger H, Siostrzonek P. Optimization of initial energy for cardioversion of atrial tachyarrhythmias with biphasic shocks. Am J Emerg Med 2010; 28:159-165.
Smith GD, Fry MM, Taylor D, Morgans A, Cantwell K. Effectiveness of the Valsalva Manoeuvre for reversion of supraventricular tachycardia. Cochrane Database Syst Rev 2015; 2:CD009502.
Lim SH, Anantharaman V, Teo WS, Goh PP, Tan ATH. Comparison of treatment of supraventricular tachycardia by Valsalva maneuver and carotid sinus massage. Ann Emerg Med 1998; 31:30-35.
Smith G, Morgans A, Boyle M. Use of the Valsalva manoeuvre in the prehospital setting: A review of the literature. Emerg Med J 2009; 26:8-10.
Brady WJJ, DeBehnke DJ, Wickman LL, Lindbeck G. Treatment of out-of-hospital supraventricular tachycardia: Adenosine vs verapamil. Acad Emerg Med 1996; 3(6):574-585.
Glatter KA, Cheng J, Dorostkar P, Modin G, Talwar S, Al-Nimri M, Lee RJ, Saxon LA, Lesh MD, Scheinman MM. Electrophysiologic effects of adenosine in patients with supraventricular tachycardia. Circulation 1999; 99:1034-1040.
Delaney B, Loy J, Kelly A-M. The relative efficacy of adenosine versus verapamil for the treatment of stable paroxysmal supraventricular tachycardia in adults: A meta-analysis. Eur J Emerg Med 2011; 18:148-152.
Dougherty AH, Jackman WM, Naccarelli GV, Friday KJ, Dias VC. Acute conversion of paroxysmal supraventricular tachycardia with intravenous diltiazem. Am J Cardiol 1992; 70:587-592.
Hood MA, Smith WM. Adenosine versus verapamil in the treatment of supraventricular tachycardia: A randomized double-crossover trial. Am Heart J 1992; 123:1543-1549.
Gupta A, Naik A, Vora A, Lokhandwala Y. Comparison of efficacy of intravenous diltiazem and esmolol in terminating supraventricular tachycardia. J Assoc Physicians India 1999; 47:969-972.
Lim SH, Anantharaman V, Teo WS, Chan YH. Slow infusion of calcium channel blockers compared with intravenous adenosine in the emergency treatment of supraventricular tachycardia. Resuscitation 2009; 80:523-528.
Das G, Tschida V, Gray R, Dhurandhar R, Lester R, McGrew F, Askenazi J, Kaplan K, Emanuele M, Turlapaty P, Hua TA, Hoff J, Allin D, Laddu A. Efficacy of esmolol in the treatment and transfer of patients with supraventricular tachyarrhythmias to alternate oral antiarrhythmic agents. J Clin Pharmacol 1988; 28:746-750.
Amsterdam EA, Kulcyski J, Ridgeway MG. Efficacy of cardioselective beta-adrenergic blockade with intravenously administered metoprolol in the treatment of supraventricular tachyarrhythmias. J Clin Pharmacol 1991; 31:714-718.
Smith G, Taylor DM, Morgans A, Cameron P. Prehospital synchronized electrical cardioversion of a poorly perfused SVT patient by paramedics. Prehosp Disaster Med 2013; 28:301-304.
Wen Z-C, Chen S-A, Tai C-T, Chiang C-E, Chiou C-W, Chang M-S. Electrophysiological mechanisms and determinants of vagal maneuvers for termination of paroxysmal supraventricular tachycardia. Circulation 1998; 98:2716-2723.
Taylor DM, Wong LF. Incorrect instruction in the use of the Valsalva manoeuvre for paroxysmal supra-ventricular tachycardia is common. Emergency Medicine 2004; 16(4):284-287.
Smith G, Boyle MJ. The 10 mL syringe is useful in generating the recommended standard of 40 mmHg intrathoracic pressure for the Valsalva manoeuvre. Emerg Med Australas 2009; 21:449-454.
Layland J, Carrick D, Lee M, Oldroyd K, Berry C. Adenosine: Physiology, pharmacology, and clinical applications. JACC Cardiovasc Interv 2014; 7:581-591.
Lerman BB, Markowitz SM, Cheung JW, Liu CF, Thomas G, Ip JE. Supraventricular tachycardia. Circ Arrhythm Electrophysiol 2018; 11:e006953.
Camm AJ, Garratt CJ. Adenosine and supraventricular tachycardia. N Engl J Med 1991; 325:1621-1629.
Ng GA, Martin W, Rankin AC. Imaging of adenosine bolus transit following intravenous administration: Insights into antiarrhythmic efficacy. Heart 1999; 82:163-169.
Alabed S, Sabouni A, Providencia R, Atallah E, Qintar M, Chico TJA. Adenosine versus intravenous calcium channel antagonists for supraventricular tachycardia. Cochrane Database Syst Rev 2017; 10:CD005154.
Cabalag MS, Taylor DM, Knott JC, Buntine P, Smit D, Meyer A. Recent caffeine ingestion reduces adenosine efficacy in the treatment of paroxysmal supraventricular tachycardia. Acad Emerg Med 2010; 17:44-49.
Karydes HC, Bryant SM. Adenosine and caffeine-induced paroxysmal supraventricular tachycardia. Acad Emerg Med 2010; 17:570-570.
Burki NK, Wheeler JD, Lu-Yuan L. Intravenous adenosine and dyspnea in humans. J Appl Physiol (1985) 2005; 98:180-185.
Fragakis N, Antoniadis AP, Korantzopoulos P, Kyriakou P, Koskinas KC, Geleris P. Sinus nodal response to adenosine relates to the severity of sinus node dysfunction. Europace 2012; 14:859-864.
Ellenbogen KA, Thames MD, DiMarco JP, Sheehan H, Lerman BB. Electrophysiological effects of adenosine in the transplanted human heart. Evidence of supersensitivity. Circulation 1990; 81:821-828.
Toft J, Mortensen J, Hesse B. Risk of atrioventricular block during adenosine pharmacologic stress testing in heart transplant recipients. Am J Cardiol 1998; 82:696-697.
Flyer JN, Zuckerman WA, Richmond ME, Anderson BR, Mendelsberg TG, McAllister JM, Liberman L, Addonizio LJ, Silver ES. Prospective study of adenosine on atrioventricular nodal conduction in pediatric and young adult patients after heart transplantation. Circulation 2017; 135:2485-2493.
Ip JE, Cheung JW, Chung JH, Liu CF, Thomas G, Markowitz SM, Lerman BB. Adenosine-induced atrial fibrillation. Insights into mechanism. Circ Arrhythm Electrophysiol 2013; 6:e34-e37.
Li N, Csepe TA, Hansen BJ, Sul LV, Kalyanasundaram A, Zakharkin SO, Zhao J, Guha A, Van Wagoner DR, Kilic A, Mohler PJ, Janssen PML, Biesiadecki BJ, Hummel JD, Weiss R, Fedorov VV. adenosine-induced atrial fibrillation. Localized reentrant drivers in lateral right atria due to heterogeneous expression of adenosine A1 receptors and GIRK4 subunits in the human heart. Circulation 2016; 134:486-498.
Turley AJ, Murray S, Thambyrajah J. Pre-excited atrial fibrillation triggered by intravenous adenosine: A commonly used drug with potentially life-threatening adverse effects. Emerg Med J 2008; 25:46-48.
Garratt CJ, Griffith MJ, O'Nunain S, Ward DE, Camm AJ. Effects of intravenous adenosine on antegrade refractoriness of accessory atrioventricular connections. Circulation 1991; 84:1962-1968.
Coli S, Mantovani F, Ferro J, Gonzi G, Zardini M, Ardissino D. Adenosineinduced severe bronchospasm in a patient without pulmonary disease. Am J Emerg Med 2012; 30:2082.e3-2082.e5.
Cerqueira MD, Verani MS, Schwaiger M, Heo J, Iskandrian AS. Safety profile of adenosine stress perfusion imaging: Results from the adenoscan multicenter trial registry. J Am Coll Cardiol 1994; 23:384-389.
Balan KK, Critchley M. Is the dyspnea during adenosine cardiac stress test caused by bronchospasm?. Am Heart J 2001; 142:142-145.
Cushley MJ, Tattersfield AE, Holgate ST. Inhaled adenosine and guanosine on airway resistance in normal and asthmatic subjects. Br J Clin Pharmacol 2004; 58:S751-S755.
Burki NK, Alam M, Lee L-Y. The pulmonary effects of intravenous adenosine in asthmatic subjects. Respiratory Research 2006; 7:139-139.
Burkhart KK. Respiratory failure following adenosine administration. Am J Emerg Med 1993; 11:249-250.
DeGroff CG, Silka MJ. Bronchospasm after intravenous administration of adenosine in a patient with asthma. J Pediatr 1994; 125:822-823.
Brubaker S, Long B, Koyfman A. Alternative treatment options for atrioventricular-nodal-reentry tachycardia: An emergency medicine review. J Emerg Med 2018; 54:198-206.
Stambler BS, Dorian P, Sager PT, Wight D, Douville P, Potvin D, Shamszad P, Haberman RJ, Kuk RS, Lakkireddy DR, Teixeira JM, Bilchick KC, Damle RS, Bernstein RC, Lam WW, O'Neill G, Noseworthy PA, Venkatachalam KL, Coutu B, Mondesert B, Plat F. Etripamil nasal spray for rapid conversion of supraventricular tachycardia to sinus rhythm. J Am Coll Cardiol 2018; 72:489-497.
Olasveengen TM, de Caen AR, Mancini ME, Maconochie IK, Aickin R, Atkins DL, Berg RA, Bingham RM, Brooks SC, Castrén M, Chung SP, Considine J, Couto TB, Escalante R, Gazmuri RJ, Guerguerian AM, Hatanaka T, Koster RW, Kudenchuk PJ, Lang E, Lim SH, Løfgren B, Meaney PA, Montgomery WH, Morley PT, Morrison LJ, Nation KJ, Ng KC, Nadkarni VM, Nishiyama C, Nuthall G, Ong GY, Perkins GD, Reis AG, Ristagno G, Sakamoto T, Sayre MR, Schexnayder SM, Sierra AF, Singletary EM, Shimizu N, Smyth MA, Stanton D, Tijssen JA, Travers A, Vaillancourt C, Van de Voorde P, Hazinski MF, Nolan JP; ILCOR Collaborators. 2017 international consensus on cardiopulmonary resuscitation and emergency cardiovascular care science with treatment recommendations summary. Circulation 2017; 136:e424-e440.
Priori SG, Blomström-Lundqvist C, Mazzanti A, Blom N, Borggrefe M, Camm J, Elliott PM, Fitzsimons D, Hatala R, Hindricks G, Kirchhof P, Kjeldsen K, Kuck KH, Hernandez-Madrid A, Nikolaou N, Norekval TM, Spaulding C, Van Veldhuisen DJ, Kolh P, Lip GYH, Agewall S, Baron-Esquivias G, Boriani G, Budts W, Bueno H, Capodanno D, Carerj S, Crespo-Leiro MG, Czerny M, Deaton C, Dobrev D, Erol Ç, Galderisi M, Gorenek B, Kriebel T, Lambiase P, Lancellotti P, Lane DA, Lang I, Manolis AJ, Morais J, Moreno J, Piepoli MF, Rutten FH, Sredniawa B, Zamorano JL, Zannad F. 2015 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death. The Task Force for the Management of Patients with Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death of the European Society of Cardiology (ESC) Endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC). Eur Heart J 2015; 36:2793-2867.
Ortiz M, Martin A, Arribas F, Coll-Vinent B, Del Arco C, Peinado R, Almendral J; PROCAMIO Study Investigators. Randomized comparison of intravenous procainamide vs. intravenous amiodarone for the acute treatment of tolerated wide QRS tachycardia: The PROCAMIO study. Eur Heart J 2017; 38:1329-1335.
Buxton AE, Marchlinski FE, Doherty JU, Flores B, Josephson ME. Hazards of intravenous verapamil for sustained ventricular tachycardia. Am J Cardiol 1987; 59:1107-1110.
Dancy M, Camm AJ, Ward D. Misdiagnosis of chronic recurrent ventricular tachycardia. Lancet 1985; 326:320-323.
Crijns HJ, Lie KI. Haemodynamic deterioration after treatment with adenosine. Br Heart J 1995; 73:103.
Gorgels APM, van den Dool A, Hofs A, Mulleneers R, Smeets JLRM, Vos MA, Wellens HJJ. Comparison of procainamide and lidocaine in terminating sustained monomorphic ventricular tachycardia. Am J Cardiol 1996; 78:43-46.
Scheinman MM, Levine JH, Cannom DS, Friehling T, Kopelman HA, Chilson DA, Platia EV, Wilber DJ, Kowey PR. Dose-ranging study of intravenous amiodarone in patients with life-threatening ventricular tachyarrhythmias. Circulation 1995; 92:3264-3272.
Levine JH, Massumi A, Scheinman MM, Winkle RA, Platia EV, Chilson DA, Gomes JA, Woosley RL. Intravenous amiodarone for recurrent sustained hypotensive ventricular tachyarrhythmias. J Am Coll Cardiol 1996; 27:67-75.
Olshansky B, Sullivan RM. Inappropriate sinus tachycardia. Europace 2019; 21:194-207.
Still A-M, Raatikainen P, Ylitalo A, Kauma H, Ikäheimo M, Kesäniemi YA, Huikuri HV. Prevalence, characteristics and natural course of inappropriate sinus tachycardia. Europace 2005; 7:104-112.
Baruscotti M, Bucchi A, Milanesi R, Paina M, Barbuti A, Gnecchi-Ruscone T, Bianco E, Vitali-Serdoz L, Cappato R, DiFrancesco D. A gain-of-function mutation in the cardiac pacemaker HCN4 channel increasing cAMP sensitivity is associated with familial Inappropriate Sinus Tachycardia. Eur Heart J 2017; 38:280-288.
Ruzieh M, Moustafa A, Sabbagh E, Karim MM, Karim S. Challenges in treatment of inappropriate sinus tachycardia. Curr Cardiol Rev 2018; 14:42-44.
Brunner S, Herbel R, Drobesch C, Peters A, Massberg S, Kaab S, Sinner MF. Alcohol consumption, sinus tachycardia, and cardiac arrhythmias at the Munich Octoberfest: Results from the Munich Beer Related Electrocardiogram Workup Study (MunichBREW). Eur Heart J 2017; 38:2100-2106.
Shen WK. How to manage patients with inappropriate sinus tachycardia. Heart Rhythm 2005; 2:1015-1019.
Foster MC, Levine PA. Use of verapamil to control an inappropriate chronic sinus tachycardia. Chest 1984; 85:697-699.
Cappato R, Castelvecchio S, Ricci C, Bianco E, Vitali-Serdoz L, Gnecchi-Ruscone T, Pittalis M, De Ambroggi L, Baruscotti M, Gaeta M, Furlanello F, Di Francesco D, Lupo PP. Clinical efficacy of ivabradine in patients with inappropriate sinus tachycardia: A prospective, randomized, placebo-controlled, doubleblind, crossover evaluation. J Am Coll Cardiol 2012; 60:1323-1329.
Ptaszynski P, Kaczmarek K, Ruta J, Klingenheben T, Wranicz JK. Metoprolol succinate vs. ivabradine in the treatment of inappropriate sinus tachycardia in patients unresponsive to previous pharmacological therapy. Europace 2013; 15:116-121.
Benezet-Mazuecos J, Rubio JM, Farr E J, Quiñones MA, Sanchez-Borque P, MacIA E. Long-term outcomes of ivabradine in inappropriate sinus tachycardia patients: Appropriate efficacy or inappropriate patients. Pacing Clin Electrophysiol 2013; 36:830-836.
Calo L, Rebecchi M, Sette A, Martino A, de Ruvo E, Sciarra L, De Luca L, Zuccaro LM, Giunta G, Ciccaglioni A, Lioy E, Fedele F. Efficacy of ivabradine administration in patients affected by inappropriate sinus tachycardia. Heart Rhythm 2010; 7:1318-1323.
Ptaszynski P, Kaczmarek K, Ruta J, Klingenheben T, Wranicz JK. Ivabradine in the treatment of inappropriate sinus tachycardia in patients after successful radiofrequency catheter ablation of atrioventricular node slow pathway. Pacing Clin Electrophysiol 2013; 36:42-49.
Dias da Silva VJ, Tobaldini E, Rocchetti M, Wu MA, Malfatto G, Montano N, Zaza A. Modulation of sympathetic activity and heart rate variability by ivabradine. Cardiovasc Res 2015; 108:31-38.
Ptaszynski P, Kaczmarek K, Ruta J, Klingenheben T, Cygankiewicz I, Wranicz JK. Ivabradine in combination with metoprolol succinate in the treatment of inappropriate sinus tachycardia. J Cardiovasc Pharmacol Ther 2013; 18:338-344.
Regitz-Zagrosek V, Roos-Hesselink JW, Bauersachs J, Blomström-Lundqvist C, Cífkova R, De Bonis M, Iung B, Johnson MR, Kintscher U, Kranke P, Lang IM, Morais J, Pieper PG, Presbitero P, Price S, Rosano GMC, Seeland U, Simoncini T, Swan L, Warnes CA; ESC Scientific Document Group. 2018 ESC Guidelines for the management of cardiovascular diseases during pregnancy. Eur Heart J 2018; 39:3165-3241.
Yu J, Zhou Z, Tay-Sontheimer J, Levy RH, Ragueneau-Majlessi I. Risk of clinically relevant pharmacokinetic-based drug-drug interactions with drugs approved by the U.S. Food and Drug Administration between 2013 and 2016. Drug Metab Dispos 2018; 46:835-845.
Man KC, Knight B, Tse H-F, Pelosi F, Michaud GF, Flemming M, Strickberger SA, Morady F. Radiofrequency catheter ablation of inappropriate sinus tachycardia guided by activation mapping. J Am Coll Cardiol 2000; 35:451-457.
Marrouche NF, Beheiry S, Tomassoni G, Cole C, Bash D, Dresing T, Saliba W, Abdul-Karim A, Tchou P, Schweikert R, Leonelli F, Natale A. Three-dimensional nonfluoroscopic mapping and ablation of inappropriate sinus tachycardia: Procedural strategies and long-term outcome. J Am Coll Cardiol 2002; 39:1046-1054.
Callans DJ, Ren J-F, Schwartzman D, Gottlieb CD, Chaudhry FA, Marchlinski FE. Narrowing of the superior vena cava-right atrium junction during radiofrequency catheter ablation for inappropriate sinus tachycardia: Analysis with intracardiac echocardiography. J Am Coll Cardiol 1999; 33:1667-1670.
Takemoto M, Mukai Y, Inoue S, Matoba T, Nishizaka M, Ide T, Chishaki A, Sunagawa K. Usefulness of non-contact mapping for radiofrequency catheter ablation of inappropriate sinus tachycardia: new procedural strategy and longterm clinical outcome. Intern Med 2012; 51:357-362.
Koplan BA, Parkash R, Couper G, Stevenson WG. Combined epicardial-endocardial approach to ablation of inappropriate sinus tachycardia. J Cardiovasc Electrophysiol 2004; 15:237-240.
Jacobson JT, Kraus A, Lee R, Goldberger JJ. Epicardial/endocardial sinus node ablation after failed endocardial ablation for the treatment of inappropriate sinus tachycardia. J Cardiovasc Electrophysiol 2014; 25:236-241.
Rodríguez-Mañero M, Kreidieh B, Al Rifai M, Ibarra-Cortez S, Schurmann P, Alvarez PA, Fernandez-Lopez XA, García-Seara J, Martínez-Sande L, Gonzalez-Juanatey JR, Valderrabano M. Ablation of inappropriate sinus tachycardia: A systematic review of the literature. JACC Clin Electrophysiol 2017; 3:253-265.
Klein I, Ojamaa K. Thyroid hormone and the cardiovascular system. N Engl J Med 2001; 344:501-509.
Gomes JA, Hariman RJ, Kang PS, Chowdry IH. Sustained symptomatic sinus node reentrant tachycardia: Incidence, clinical significance, electrophysiologic observations and the effects of antiarrhythmic agents. J Am Coll Cardiol 1985; 5:45-57.
Malik AK, Ching CK, Liew R, Chong DT, Teo WS. Successful ablation of sinus node reentrant tachycardia using remote magnetic navigation system. Europace 2012; 14:455-456.
Cossu SF, Steinberg JS. Supraventricular tachyarrhythmias involving the sinus node: Clinical and electrophysiologic characteristics. Prog Cardiovasc Dis 1998; 41:51-63.
Sanders WE Jr, Sorrentino RA, Greenfield RA, Shenasa H, Hamer ME, Wharton JM. Catheter ablation of sinoatrial node reentrant tachycardia. J Am Coll Cardiol 1994; 23:926-934.
Fu Q, VanGundy TB, Shibata S, Auchus RJ, Williams GH, Levine BD. Exercise training versus propranolol in the treatment of the postural orthostatic tachycardia syndrome. Hypertension 2011; 58:167-175.
Fu Q, VanGundy TB, Galbreath MM, Shibata S, Jain M, Hastings JL, Bhella PS, Levine BD. Cardiac origins of the postural orthostatic tachycardia syndrome. J Am Coll Cardiol 2010; 55:2858-2868.
Winker R, Barth A, Bidmon D, Ponocny I, Weber M, Mayr O, Robertson D, Diedrich A, Maier R, Pilger A, Haber P, Rüdiger HW. Endurance exercise training in orthostatic intolerance. A randomized, controlled trial 2005; 45: 391-398.
Jacob G, Shannon JR, Black B, Biaggioni I, Mosqueda-Garcia R, Robertson RM, Robertson D. Effects of volume loading and pressor agents in idiopathic orthostatic tachycardia. Circulation 1997; 96:575-580.
Raj SR, Biaggioni I, Yamhure PC, Black BK, Paranjape SY, Byrne DW, Robertson D. Renin-aldosterone paradox and perturbed blood volume regulation underlying postural tachycardia syndrome. Circulation 2005; 111:1574-1582.
Raj SR, Black BK, Biaggioni I, Paranjape SY, Ramirez M, Dupont WD, Robertson D. Propranolol decreases tachycardia and improves symptoms in the postural tachycardia syndrome. Less is more. Circulation 2009; 120:725-734.
Kanjwal K, Karabin B, Sheikh M, Elmer L, Kanjwal Y, Saeed B, Grubb BP. Pyridostigmine in the treatment of postural orthostatic tachycardia: A singlecenter experience. Pacing Clin Electrophysiol 2011; 34:750-755.
Raj SR, Black BK, Biaggioni I, Harris PA, Robertson D. Acetylcholinesterase inhibition improves tachycardia in postural tachycardia syndrome. Circulation 2005; 111:2734-2740.
McDonald C, Frith J, Newton JL. Single centre experience of ivabradine in postural orthostatic tachycardia syndrome. Europace 2011; 13:427-430.
Glukhov AV, Hage LT, Hansen BJ, Pedraza-Toscano A, Vargas-Pinto P, Hamlin RL, Weiss R, Carnes CA, Billman GE, Fedorov VV. Sinoatrial node reentry in a canine chronic left ventricular infarct model: Role of intranodal fibrosis and heterogeneity of refractoriness. Circ Arrhythm Electrophysiol 2013; 6:984-994.
Sheldon RS, Grubb BP, Olshansky B, Shen W-K, Calkins H, Brignole M, Raj SR, Krahn AD, Morillo CA, Stewart JM, Sutton R, Sandroni P, Friday KJ, Hachul DT, Cohen MI, Lau DH, Mayuga KA, Moak JP, Sandhu RK, Kanjwal K. 2015 Heart Rhythm Society expert consensus statement on the diagnosis and treatment of postural tachycardia syndrome, inappropriate sinus tachycardia, and vasovagal syncope. Heart Rhythm 2015; 12:e41-e63.
Bryarly M, Phillips LT, Fu Q, Vernino S, Levine BD. Postural orthostatic tachycardia syndrome: JACC Focus Seminar. J Am Coll Cardiol 2019; 73:1207-1228.
Benarroch EE. Postural tachycardia syndrome: A heterogeneous and multifactorial disorder. Mayo Clinic Proceedings 2012; 87:1214-1225.
Tomichi Y, Kawano H, Mukaino A, Chiba A, Doi Y, Arakawa S, Ishimatsu T, Fukae S, Abiru N, Maemura K. Postural orthostatic tachycardia in a patient with type 2 diabetes with diabetic neuropathy. Int Heart J 2018; 59:1488-1490.
Low PA, Sandroni P, Joyner M, Shen WK. Postural tachycardia syndrome (POTS). J Cardiovasc Electrophysiol 2009; 20:352-358.
Fedorowski A. Postural orthostatic tachycardia syndrome: Clinical presentation, aetiology, and management. J Intern Med 2018; 285:352-366.
Poutiainen AM, Koistinen MJ, Airaksinen KE, Hartikainen EK, Kettunen RVJ, Karjalainen JE, Huikuri HV. Prevalence and natural course of ectopic atrial tachycardia. Eur Heart J 1999; 20:694-700.
Kistler PM, Sanders P, Fynn SP, Stevenson IH, Hussin A, Vohra JK, Sparks PB, Kalman JM. Electrophysiological and electrocardiographic characteristics of focal atrial tachycardia originating from the pulmonary veins: Acute and long-term outcomes of radiofrequency ablation. Circulation 2003; 108:1968-1975.
Haissaguerre M, Jais P, Shah DC, Takahashi A, Hocini M, Quiniou G, Garrigue S, Le Mouroux A, Le Metayer P, Clementy J. Spontaneous initiation of atrial fibrillation by ectopic beats originating in the pulmonary veins. N Engl J Med 1998; 339:659-666.
Kistler PM, Roberts-Thomson KC, Haqqani HM, Fynn SP, Singarayar S, Vohra JK, Morton JB, Sparks PB, Kalman JM. P-wave morphology in focal atrial tachycardia: Development of an algorithm to predict the anatomic site of origin. J Am Coll Cardiol 2006; 48:1010-1017.
Chen SA, Chiang CE, Yang CJ, Cheng CC, Wu TJ, Wang SP, Chiang BN, Chang MS. Sustained atrial tachycardia in adult patients. Electrophysiological characteristics, pharmacological response, possible mechanisms, and effects of radiofrequency ablation. Circulation 1994; 90:1262-1278.
Mehta AV, Sanchez GR, Sacks EJ, Casta A, Dunn JM, Donner RM. Ectopic automatic atrial tachycardia in children: Clinical characteristics, management and follow-up. J Am Coll Cardiol 1988; 11:379-385.
Hohnloser SH, Zabel M. Short- and long-term efficacy and safety of flecainide acetate for supraventricular arrhythmias. Am J Cardiol 1992; 70:A3-A10.
Kunze K-P, Kuck K-H, Schlüter M, Bleifeld W. Effect of encainide and flecainide on chronic ectopic atrial tachycardia. J Am Coll Cardiol 1986; 7:1121-1126.
Eidher U, Freihoff F, Kaltenbrunner W, Steinbach K. Efficacy and safety of ibutilide for the conversion of monomorphic atrial tachycardia. Pacing Clin Electrophysiol 2006; 29:358-362.
Vietti-Ramus G, Veglio F, Marchisio U, Burzio P, Latini R. Efficacy and safety of short intravenous amiodarone in supraventricular tachyarrhythmias. Int J Cardiol 1992; 35:77-85.
Salem JE, Dureau P, Funck-Brentano C, Hulot JS, El-Aissaoui M, Aissaoui N, Urien S, Faisy C. Effectiveness of heart rate control on hemodynamics in critically ill patients with atrial tachyarrhythmias managed by amiodarone. Pharmacol Res 2017; 122:118-126.
Anguera I, Brugada J, Roba M, Mont Ls, Aguinaga L, Geelen P, Brugada P. Outcomes after radiofrequency catheter ablation of atrial tachycardia. Am J Cardiol 2001; 87:886-890.
Biviano AB, Bain W, Whang W, Leitner J, Dizon J, Hickey K, Garan H. Focal left atrial tachycardias not associated with prior catheter ablation for atrial fibrillation: Clinical and electrophysiological characteristics. Pacing Clin Electrophysiol 2012; 35:17-27.
Medi C, Kalman JM, Haqqani H, Vohra JK, Morton JB, Sparks PB, Kistler PM. Tachycardia-mediated cardiomyopathy secondary to focal atrial tachycardia: Longterm outcome after catheter ablation. J Am Coll Cardiol 2009; 53:1791-1797.
Ouyang F, Ma J, Ho SY, Bänsch D, Schmidt B, Ernst S, Kuck K-H, Liu S, Huang H, Chen M, Chun J, Xia Y, Satomi K, Chu H, Zhang S, Antz M. Focal atrial tachycardia originating from the non-coronary aortic sinus: Electrophysiological characteristics and catheter ablation. J Am Coll Cardiol 2006; 48:122-131.
Heusch A, Kramer HH, Krogmann ON, Rammos S, Bourgeois M. Clinical experience with propafenone for cardiac arrhythmias in the young. Eur Heart J 1994; 15:1050-1056.
Meles E, Carbone C, Maggiolini S, Moretti P, CC DECGentile G, Gnecchi-Ruscone T. A case of atrial tachycardia treated with ivabradine as bridge to ablation. J Cardiovasc Electrophysiol 2015; 26:565-568.
Bohora S, Lokhandwala Y, Parekh P, Vasavda A. Reversal of tachycardiomyopathy due to left atrial tachycardia by ivabradine. J Cardiovasc Electrophysiol 2011; 22:340-342.
Guccione P, Paul T, Garson A Jr. Long-term follow-up of amiodarone therapy in the young: Continued efficacy, unimpaired growth, moderate side effects. J Am Coll Cardiol 1990; 15:1118-1124.
von Bernuth G, Engelhardt W, Kramer HH, Singer H, Schneider P, Ulmer H, Brodherr-Heberlein S, Kienast W, Lang D, Lindinger A, Schmidt K. Atrial automatic tachycardia in infancy and childhood. Eur Heart J 1992; 13:1410-1415.
Spector P, Reynolds MR, Calkins H, Sondhi M, Xu Y, Martin A, Williams CJ, Sledge I. Meta-analysis of ablation of atrial flutter and supraventricular tachycardia. Am J Cardiol 2009; 104:671-677.
Bohnen M, Stevenson WG, Tedrow UB, Michaud GF, John RM, Epstein LM, Albert CM, Koplan BA. Incidence and predictors of major complications from contemporary catheter ablation to treat cardiac arrhythmias. Heart Rhythm 2011; 8:1661-1666.
Keegan R, Aguinaga L, Fenelon G, Uribe W, Rodriguez Diez G, Scanavacca M, Patete M, Carhuaz RZ, Labadet C, De Zuloaga C, Pozzer D, Scazzuso F. The first Latin American Catheter Ablation Registry. Europace 2015; 17:794-800.
Steinbeck G, Sinner MF, Lutz M, Muller-Nurasyid M, Kaab S, Reinecke H. Incidence of complications related to catheter ablation of atrial fibrillation and atrial flutter: A nationwide in-hospital analysis of administrative data for Germany in 2014. Eur Heart J 2018; 39:4020-4029.
Konig S, Ueberham L, Schuler E, Wiedemann M, Reithmann C, Seyfarth M, Sause A, Tebbenjohanns J, Schade A, Shin DI, Staudt A, Zacharzowsky U, Andrie R, Wetzel U, Neuser H, Wunderlich C, Kuhlen R, Tijssen JGP, Hindricks G, Bollmann A. In-hospital mortality of patients with atrial arrhythmias: Insights from the German-wide Helios hospital network of 161 502 patients and 34 025 arrhythmia-related procedures. Eur Heart J 2018; 39:3947-3957.
Katritsis DG, Zografos T, Siontis KC, Giannopoulos G, Muthalaly RG, Liu Q, Latchamsetty R, Varga Z, Deftereos S, Swerdlow C, Callans DJ, Miller JM, Morady F, John RM, Stevenson WG. End-points for successful slow pathway catheter ablation in typical and atypical atrioventricular nodal reentrant tachycardia: A contemporary, multicenter study. JACC Clin Electrophysiol 2019; 5:113-119.
Kastor JA. Multifocal atrial tachycardia. N Engl J Med 1990; 322:1713-1717.
Bradley DJ, Fischbach PS, Law IH, Serwer GA, Dick M II. The clinical course of multifocal atrial tachycardia in infants and children. J Am Coll Cardiol 2001; 38:401-408.
Iseri LT, Fairshter RD, Hardemann JL, Brodsky MA. Magnesium and potassium therapy in multifocal atrial tachycardia. Am Heart J 1985; 110:789-794.
Marchlinski FE, Miller JM. Atrial arrhythmias exacerbated by theophylline: Response to verapamil and evidence for triggered activity in man. Chest 1985; 88:931-934.
Salerno DM, Anderson B, Sharkey PJ, Iber C. Intravenous verapamil for treatment of multifocal atrial tachycardia with and without calcium pretreatment. Ann Intern Med 1987; 107:623-628.
Arsura E, Lefkin AS, Scher DL, Solar M, Tessler S. A randomized, double-blind, placebo-controlled study of verapamil and metoprolol in treatment of multifocal atrial tachycardia. Am J Med 1988; 85:519-524.
Pierce WJ, McGroary K. Multifocal atrial tachycardia and Ibutilide. Am J Geriatr Cardiol 2001; 10:193-195.
Ueng KC, Lee SH, Wu DJ, Lin CS, Chang MS, Chen SA. Radiofrequency catheter modification of atrioventricular junction in patients with COPD and medically refractory multifocal atrial tachycardia. Chest 2000; 117:52-59.
Hazard PB, Burnett CR. Verapamil in multifocal atrial tachycardia: Hemodynamic and respiratory changes. Chest 1987; 91:68-70.
Levine JH, Michael JR, Guarnieri T. Treatment of multifocal atrial tachycardia with verapamil. N Engl J Med 1985; 312:21-25.
Hazard PB, Burnett CR. Treatment of multifocal atrial tachycardia with metoprolol. Crit Care Med 1987; 15:20-25.
Saoudi N, Cosio F, Waldo A, Chen S-A, Iesaka Y, Lesh M, Saksena S, Salerno J, Schoels W. Classification of atrial flutter and regular atrial tachycardia according to electrophysiologic mechanism and anatomic bases: A statement from a joint expert group from the Working Group of Arrhythmias of the European Society of Cardiology and the North American Society of Pacing and Electrophysiology. J Cardiovasc Electrophysiol 2001; 12:852-866.
Saoudi N, Nair M, Abdelazziz A, Poty H, Daou A, Anselme F, Letac B. Electrocardiographic patterns and results of radiofrequency catheter ablation of clockwise type I atrial flutter. J Cardiovasc Electrophysiol 1996; 7:931-942.
Olgin JE, Kalman JM, Fitzpatrick AP, Lesh MD. Role of right atrial endocardial structures as barriers to conduction during human type I atrial flutter. Activation and entrainment mapping guided by intracardiac echocardiography. Circulation 1995; 92:1839-1848.
Chugh A, Latchamsetty R, Oral H, Elmouchi D, Tschopp D, Reich S, Igic P, Lemerand T, Good E, Bogun F, Pelosi F Jr, Morady F. Characteristics of cavotricuspid isthmus-dependent atrial flutter after left atrial ablation of atrial fibrillation. Circulation 2006; 113:609-615.
Stevenson IH, Kistler PM, Spence SJ, Vohra JK, Sparks PB, Morton JB, Kalman JM. Scar-related right atrial macroreentrant tachycardia in patients without prior atrial surgery: Electroanatomic characterization and ablation outcome. Heart Rhythm 2005; 2:594-601.
Havranek S, Simek J, Stovícek P, Wichterle D. Distribution of mean cycle length in cavo-tricuspid isthmus dependent atrial flutter. Physiol Res 2012; 61: 43-51.
Barbato G, Carinci V, Tomasi C, Frassineti V, Margheri M, Di Pasquale G. Is electrocardiography a reliable tool for identifying patients with isthmusdependent atrial flutter?. Europace 2009; 11:1071-1076.
Halligan SC, Gersh BJ, Brown RD Jr, Rosales AG, Munger TM, Shen WK, Hammill SC, Friedman PA. The natural history of lone atrial flutter. Ann Intern Med 2004; 140:265-268.
Chinitz JS, Gerstenfeld EP, Marchlinski FE, Callans DJ. Atrial fibrillation is common after ablation of isolated atrial flutter during long-term follow-up. Heart Rhythm 2007; 4:1029-1033.
Pérez FJ, Schubert CM, Parvez B, Pathak V, Ellenbogen KA, Wood MA. Longterm outcomes after catheter ablation of cavo-tricuspid isthmus dependent atrial flutter. A meta-analysis. Circ Arrhythm Electrophysiol 2009; 2:393-401.
Reithmann C, Hoffmann E, Spitzlberger G, Dorwarth U, Gerth A, Remp T, Steinbeck G. Catheter ablation of atrial flutter due to amiodarone therapy for paroxysmal atrial fibrillation. Eur Heart J 2000; 21:565-572.
Bertaglia E, Bonso A, Zoppo F, Proclemer A, Verlato R, Cor O L, Mantovan R, Themistoclakis S, Raviele A, Pascotto P. Different clinical courses and predictors of atrial fibrillation occurrence after transisthmic ablation in patients with preablation lone atrial flutter, coexistent atrial fibrillation, and drug induced atrial flutter. Pacing Clin Electrophysiol 2004; 27:1507-1512.
Nabar A, Rodriguez LM, Timmermans C, van Mechelen R, Wellens HJJ. Class IC antiarrhythmic drug induced atrial flutter: Electrocardiographic and electrophysiological findings and their importance for long term outcome after right atrial isthmus ablation. Heart 2001; 85:424-429.
Luchsinger JA, Steinberg JS. Resolution of cardiomyopathy after ablation of atrial flutter. J Am Coll Cardiol 1998; 32:205-210.
Pizzale S, Lemery R, Green MS, Gollob MH, Tang ASL, Birnie DH. Frequency and predictors of tachycardia-induced cardiomyopathy in patients with persistent atrial flutter. Can J Cardiol 2009; 25:469-472.
Ellenbogen KA, Dias VC, Cardello FP, Strauss WE, Simonton CA, Pollak SJ, Wood MA, Stambler BS. Safety and efficacy of intravenousdiltiazem in atrial fibrillation or atrial flutter. Am J Cardiol 1995; 75:45-49.
Salerno DM, Dias VC, Kleiger RE, Tschida VH, Sung RJ, Sami M, Giorgi LV. Efficacy and safety of intravenous diltiazem for treatment of atrial fibrillation and atrial flutter. Am J Cardiol 1989; 63:1046-1051.
Platia EV, Michelson EL, Porterfield JK, Das G. Esmolol versus verapamil in the acute treatment of atrial fibrillation or atrial flutter. Am J Cardiol 1989; 63:925-929.
Ellenbogen KA, Dias VC, Plumb VJ, Heywood JT, Mirvis DM. A placebocontrolled trial of continuous intravenous diltiazem infusion for 24-hour heart rate control during atrial fibrillation and atrial flutter: A multicenter study. J Am Coll Cardiol 1991; 18:891-897.
Delle Karth G, Geppert A, Neunteufl T, Priglinger U, Haumer M, Gschwandtner M, Siostrzonek P, Heinz G. Amiodarone versus diltiazem for rate control in critically ill patients with atrial tachyarrhythmias. Crit Care Med 2001; 29:1149-1153.
Clemo HF, Wood MA, Gilligan DM, Ellenbogen KA. Intravenous amiodarone for acute heart rate control in the critically ill patient with atrial tachyarrhythmias. Am J Cardiol 1998; 81:594-598.
Ghali WA, Wasil BI, Brant R, Exner DV, Cornuz J. Atrial flutter and the risk of thromboembolism: A systematic review and meta-analysis. Am J Med 2005; 118:101-107.
Vadmann H, Nielsen PB, Hjortshøj SP, Riahi S, Rasmussen LH, Lip GYH, Larsen TB. Atrial flutter and thromboembolic risk: A systematic review. Heart 2015; 101:1446-1455.
Seidl K, Hauer B, Schwick NG, Zellner D, Zahn R, Senges J. Risk of thromboembolic events in patients with atrial flutter. Am J Cardiol 1998; 82:580-583.
Wood KA, Eisenberg SJ, Kalman JM, Drew BJ, Saxon LA, Lee RJ, Lesh MD, Scheinman MM. Risk of thromboembolism in chronic atrial flutter. Am J Cardiol 1997; 79:1043-1047.
Lin YS, Chen YL, Chen TH, Lin MS, Liu CH, Yang TY, Chung CM, Chen MC. Comparison of clinical outcomes among patients with atrial fibrillation or atrial flutter stratified by CHA2DS2-VASc score. JAMA Netw Open 2018; 1:e180941.
Chen YL, Lin YS, Wang HT, Liu WH, Chen HC, Chen MC. Clinical outcomes of solitary atrial flutter patients using anticoagulation therapy: A national cohort study. Europace 2019; 21:313-321.
Schmidt H, von der Recke G, Illien S, Lewalter T, Schimpf R, Wolpert C, Becher H, Lüderitz B, Omran H. Prevalence of left atrial chamber and appendage thrombi in patients with atrial flutter and its clinical significance. J Am Coll Cardiol 2001; 38:778-784.
Gallagher MM, Guo X-H, Poloniecki JD, Guan Yap Y, Ward D, Camm AJ. Initial energy setting, outcome and efficiency in direct current cardioversion of atrial fibrillation and flutter. J Am Coll Cardiol 2001; 38:1498-1504.
Van Gelder IC, Crijns HJ, Van Gilst WH, Verwer R, Lie KI. Prediction of uneventful cardioversion and maintenance of sinus rhythm from direct-current electrical cardioversion of chronic atrial fibrillation and flutter. Am J Cardiol 1991; 68:41-46.
Crijns HJGM, Van Gelder IC, Kingma JH, Dunselman PHJM, Gosselink ATM, Lie KI. Atrial flutter can be terminated by a class III antiarrhythmic drug but not by a class IC drug. Eur Heart J 1994; 15:1403-1408.
Stambler BS, Wood MA, Ellenbogen KA, Perry KT, Wakefield LK, VanderLugt JT. Efficacy and safety of repeated intravenous doses of ibutilide for rapid conversion of atrial flutter or fibrillation. Circulation 1996; 94:1613-1621.
Ellenbogen KA, Stambler BS, Wood MA, Sager PT, Wesley RC, Meissner MD, Zoble RG, Wakefield LK, Perry KT, Vanderlugtt JT, Ibutilide I. Efficacy of intravenous ibutilide for rapid termination of atrial fibrillation and atrial flutter: A dose-response study. J Am Coll Cardiol 1996; 28:130-136.
Falk MDFRH, Pollak MDA, Singh MDFSN, Friedrich MDT. Intravenous dofetilide, a class III antiarrhythmic agent, for the termination of sustained atrial fibrillation or flutter. J Am Coll Cardiol 1997; 29:385-390.
Stambler BS, Wood MA, Ellenbogen KA. Antiarrhythmic actions of intravenous ibutilide compared with procainamide during human atrial flutter and fibrillation: Electrophysiological determinants of enhanced conversion efficacy. Circulation 1997; 96:4298-4306.
Volgman AS, Carberry PA, Stambler B, Lewis WR, Dunn GH, Perry KT, VanderLugt JT, Kowey PR. Conversion efficacy and safety of intravenous ibutilide compared with intravenous procainamide in patients with atrial flutter or fibrillation. J Am Coll Cardiol 1998; 31:1414-1419.
Vos MA, Golitsyn SR, Stangl K, Ruda MY, Van Wijk L, Harry JD, Perry KT, Touboul P, Steinbeck G, Wellens HJJ. Superiority of ibutilide (a new class III agent) over dl-sotalol in converting atrial flutter and atrial fibrillation. Heart 1998; 79:568-575.
Singh S, Zoble RG, Yellen L, Brodsky MA, Feld GK, Berk M, Billing CB. Efficacy and safety of oral dofetilide in converting to and maintaining sinus rhythm in patients with chronic atrial fibrillation or atrial flutter. The Symptomatic Atrial Fibrillation Investigative Research on Dofetilide (SAFIRE-D) study 2000; 102: 2385-2390.
Peters RW, Shorofsky SR, Pelini M, Olsovsky M, Gold MR. Overdrive atrial pacing for conversion of atrial flutter: Comparison of postoperative with nonpostoperative patients. Am Heart J 1999; 137:100-103.
Gillis AM, Unterberg-Buchwald C, Schmidinger H, Massimo S, Wolfe K, Kavaney DJ, Otterness MF, Hohnloser SH. Safety and efficacy of advanced atrial pacing therapies for atrial tachyarrhythmias in patients with a new implantable dual chamber cardioverter-defibrillator. J Am Coll Cardiol 2002; 40: 1653-1659.
Mitchell AR, Spurrell PA, Cheatle L, Sulke N. Effect of atrial antitachycardia pacing treatments in patients with an atrial defibrillator: Randomised study comparing subthreshold and nominal pacing outputs. Heart 2002; 87:433-437.
Rhodes LA, Walsh EP, Saul JP. Conversion of atrial flutter in pediatric patients by transesophageal atrial pacing: A safe, effective, minimally invasive procedure. Am Heart J 1995; 130:323-327.
Natale A, Newby KH, Pisano E, Leonelli F, Fanelli R, Potenza D, Beheiry S, Tomassoni G. Prospective randomized comparison of antiarrhythmic therapy versus first-line radiofrequency ablation in patients with atrial flutter. J Am Coll Cardiol 2000; 35:1898-1904.
Da Costa A, Thévenin J, Roche F, Romeyer-Bouchard C, Abdellaoui L, Messier M, Denis L, Faure E, Gonthier R, Kruszynski G, Pages JM, Bonijoly S, Lamaison D, Defaye P, Barthélemy JC, Gouttard T, Isaaz K. Results from the Loire-Ardèche-Drôme-Isère-Puy-de-Dôme (LADIP) trial on atrial flutter, a multicentric prospective randomized study comparing amiodarone and radiofrequency ablation after the first episode of symptomatic atrial flutter. Circulation 2006; 114:1676-1681.
Satomi K, Chun KRJ, Tilz R, Bansch D, Ernst S, Antz M, Schmidt B, Kuck K-H, Ouyang F. Catheter ablation of multiple unstable macroreentrant tachycardia within the right atrium free wall in patients without previous cardiac surgery. Circ Arrhythm Electrophysiol 2010; 3:24-31.
Jais P, Shah DC, Haissaguerre M, Hocini M, Peng JT, Takahashi A, Garrigue S, Le Metayer P, Clementy J. Mapping and ablation of left atrial flutters. Circulation 2000; 101:2928-2934.
Kall JG, Rubenstein DS, Kopp DE, Burke MC, Verdino RJ, Lin AC, Johnson CT, Cooke PA, Wang ZG, Fumo M, Wilber DJ. Atypical atrial flutter originating in the right atrial free wall. Circulation 2000; 101:270-279.
Nakagawa H, Shah N, Matsudaira K, Overholt E, Chandrasekaran K, Beckman KJ, Spector P, Calame JD, Rao A, Hasdemir C, Otomo K, Wang Z, Lazzara R, Jackman WM. Characterization of reentrant circuit in macroreentrant right atrial tachycardia after surgical repair of congenital heart disease: Isolated channels between scars allow "focal" ablation. Circulation 2001; 103:699-709.
Ouyang F, Ernst S, Vogtmann T, Goya M, Volkmer M, Schaumann A, Bansch D, Antz M, Kuck K-H. Characterization of reentrant circuits in left atrial macroreentrant tachycardia: Critical isthmus block can prevent atrial tachycardia recurrence. Circulation 2002; 105:1934-1942.
Tai C-T, Huang J-L, Lin Y-K, Hsieh M-H, Lee P-C, Ding Y-A, Chang M-S, Chen S-A. Noncontact three-dimensional mapping and ablation of upper loop reentry originating in the right atrium. J Am Coll Cardiol 2002; 40:746-753.
Blackshear JL, Stambler BS, Strauss WE, Roy D, Dias VC, Beach CL, Ebener MK. Control of heart rate during transition from intravenous to oral diltiazem in atrial fibrillation or flutter. Am J Cardiol 1996; 78:1246-1250.
Brodsky MA, Allen BJ, Grimes JA, Gold C. Enhanced atrioventricular conduction during atrial flutter after intravenous adenosine. N Engl J Med 1994; 330:288-289.
Strickberger SA, Man KC, Daoud EG, Goyal R, Brinkman K, Knight BP, Weiss R, Bahu M, Morady F. Adenosine-induced atrial arrhythmia: A prospective analysis. Ann Intern Med 1997; 127:417-422.
Crozier IG, Ikram H, Kenealy M, Levy L. Flecainide acetate for conversion of acute supraventricular tachycardia to sinus rhythm. Am J Cardiol 1987; 59:607-609.
Murdock CJ, Kyles AE, Yeung-Lai-Wah JA, Qi A, Vorderbrugge S, Kerr CR. Atrial flutter in patients treated for atrial fibrillation with propafenone. Am J Cardiol 1990; 66:755-757.
Bianconi L, Castro A, Dinelli M, Alboni P, Pappalardo A, Richiardi E, Santini M. Comparison of intravenously administered dofetilide versus amiodarone in the acute termination of atrial fibrillation and flutter. A multicentre, randomized, double-blind, placebo-controlled study. Eur Heart J 2000; 21:1265-1273.
Kafkas NV, Patsilinakos SP, Mertzanos GA, Papageorgiou KI, Chaveles JI, Dagadaki OK, Kelesidis KM. Conversion efficacy of intravenous ibutilide compared with intravenous amiodarone in patients with recent-onset atrial fibrillation and atrial flutter. Int J Cardiol 2007; 118:321-325.
Heisel A, Jung J, Stopp M, Schieffer H. Facilitating influence of procainamide on conversion of atrial flutter by rapid atrial pacing. Eur Heart J 1997; 18:866-869.
Katritsis DG, Josephson ME. Anticoagulation for cardioversion of acute onset atrial fibrillation: Time to revise guidelines?. JACC Clin Electrophysiol 2016; 2:495-497.
Schwartzman D, Callans DJ, Gottlieb CD, Dillon SM, Movsowitz C, Marchlinski FE. Conduction block in the inferior vena caval-tricuspid valve isthmus: Association with outcome of radiofrequency ablation of type I atrial flutter. J Am Coll Cardiol 1996; 28:1519-1531.
De Bortoli A, Shi LB, Ohm OJ, Hoff PI, Schuster P, Solheim E, Chen J. Incidence and clinical predictors of subsequent atrial fibrillation requiring additional ablation after cavotricuspid isthmus ablation for typical atrial flutter. Scand Cardiovasc J 2017; 51:123-128.
Benditt DG, Williams JH, Jin J, Deering TF, Zucker R, Browne K, Chang-Sing P, Singh BN. Maintenance of sinus rhythm with oral d, l-Sotalol therapy in patients with symptomatic atrial fibrillation and/or atrial flutter. d, l-Soltalol Atrial Fibrillation/Flutter Study Group. Am J Cardiol 1999; 84:270-277.
Grimm RA, Stewart WJ, Arheart KL, Thomas JD, Klein AL. Left atrial appendage "stunning" after electrical cardioversion of atrial flutter: An attenuated response compared with atrial fibrillation as the mechanism for lower susceptibility to thromboembolic events. J Am Coll Cardiol 1997; 29:582-589.
Bochoeyer A, Yang Y, Cheng J, Lee RJ, Keung EC, Marrouche NF, Natale A, Scheinman MM. Surface electrocardiographic characteristics of right and left atrial flutter. Circulation 2003; 108:60-66.
Cheng J, Cabeen WR Jr, Scheinman MM. Right atrial flutter due to lower loop reentry: Mechanism and anatomic substrates. Circulation 1999; 99:1700-1705.
Zhang S, Younis G, Hariharan R, Ho J, Yang Y, Ip J, Thakur RK, Seger J, Scheinman MM, Cheng J. Lower loop reentry as a mechanism of clockwise right atrial flutter. Circulation 2004; 109:1630-1635.
Yang Y, Cheng J, Bochoeyer A, Hamdan MH, Kowal RC, Page R, Lee RJ, Steiner PR, Saxon LA, Lesh MD, Modin GW, Scheinman MM. Atypical right atrial flutter patterns. Circulation 2001; 103:3092-3098.
Yang Y, Varma N, Badhwar N, Tanel RE, Sundara S, Lee RJ, Lee BK, Tseng ZH, Marcus GM, Kim AM, Olgin JE, Scheinman MM. Prospective observations in the clinical and electrophysiological characteristics of intra-isthmus reentry. J Cardiovasc Electrophysiol 2010; 21:1099-1106.
Zrenner B, Dong JUN, Schreieck J, Ndrepepa G, Meisner H, Kaemmerer H, Schömig A, Hess J, Schmitt C. Delineation of intra-atrial reentrant tachycardia circuits after mustard operation for transposition of the great arteries using biatrial electroanatomic mapping and entrainment mapping. J Cardiovasc Electrophysiol 2003; 14:1302-1310.
Ueda A, Suman-Horduna I, Mantziari L, Gujic M, Marchese P, Ho SY, Babu-Narayan SV, Ernst S. Contemporary outcomes of supraventricular tachycardia ablation in congenital heart disease: A single-center experience in 116 patients. Circ Arrhythm Electrophysiol 2013; 6:606-613.
Akca F, Bauernfeind T, De Groot NMS, Shalganov T, Schwagten B, Szili-Torok T. The presence of extensive atrial scars hinders the differential diagnosis of focal or macroreentrant atrial tachycardias in patients with complex congenital heart disease. Europace 2014; 16:893-898.
Shah D, Jais P, Takahashi A, Hocini M, Peng JT, Clementy J, Haissaguerre M. Dual-loop intra-atrial reentry in humans. Circulation 2000; 101:631-639.
Scaglione M, Caponi D, Ebrille E, Di Donna P, Di Clemente F, Battaglia A, Raimondo C, Appendino M, Gaita F. Very long-term results of electroanatomic-guided radiofrequency ablation of atrial arrhythmias in patients with surgically corrected atrial septal defect. Europace 2014; 16:1800-1807.
Gucuk Ipek E, Marine JE, Habibi M, Chrispin J, Lima J, Rickard J, Spragg D, Zimmerman SL, Zipunnikov V, Berger R, Calkins H, Nazarian S. Association of left atrial function with incident atypical atrial flutter after atrial fibrillation ablation. Heart Rhythm 2016; 13:391-398.
Gerstenfeld EP, Callans DJ, Dixit S, Russo AM, Nayak H, Lin D, Pulliam W, Siddique S, Marchlinski FE. Mechanisms of organized left atrial tachycardias occurring after pulmonary vein isolation. Circulation 2004; 110:1351-1357.
Wasmer K, Mönnig G, Bittner A, Dechering D, Zellerhoff S, Milberg P, Köbe J, Eckardt L. Incidence, characteristics, and outcome of left atrial tachycardias after circumferential antral ablation of atrial fibrillation. Heart Rhythm 2012; 9:1660-1666.
Satomi K, Bänsch D, Tilz R, Chun J, Ernst S, Antz M, Greten H, Kuck K-H, Ouyang F. Left atrial and pulmonary vein macroreentrant tachycardia associated with double conduction gaps: A novel type of man-made tachycardia after circumferential pulmonary vein isolation. Heart Rhythm 2008; 5:43-51.
Katritsis D, Wood MA, Shepard RK, Giazitzoglou E, Kourlaba G, Ellenbogen KA. Atrial arrhythmias following ostial or circumferential pulmonary vein ablation. J Interv Card Electrophysiol 2006; 16:123-130.
Barbhaiya CR, Baldinger SH, Kumar S, Chinitz JS, Enriquez AD, John R, Stevenson WG, Michaud GF. Downstream overdrive pacing and intracardiac concealed fusion to guide rapid identification of atrial tachycardia after atrial fibrillation ablation. Europace 2018; 20:596-603.
Johner N, Shah DC, Jousset F, Dall'Aglio PB, Namdar M. Electrophysiological and anatomical correlates of sites with postpacing intervals shorter than tachycardia cycle length in atypical atrial flutter. Circ Arrhythm Electrophysiol 2019; 12:e006955.
Yokokawa M, Latchamsetty R, Ghanbari H, Belardi D, Makkar A, Roberts B, Saint-Phard W, Sinno M, Carrigan T, Kennedy R, Suwanagool A, Good E, Crawford T, Jongnarangsin K, Pelosi F, Bogun F, Oral H, Morady F, Chugh A. Characteristics of atrial tachycardia due to small vs large reentrant circuits after ablation of persistent atrial fibrillation. Heart Rhythm 2013; 10:469-476.
Chang S-L, Tsao H-M, Lin Y-J, Lo L-W, Hu Y-F, Tuan T-C, Tsai W-C, Chang CJ, Suenari K, Huang S-Y, Tai C-T, Li C-H, Chao T-F, Wu T-J, Chen S-A. Differentiating macroreentrant from focal atrial tachycardias occurred after circumferential pulmonary vein isolation. J Cardiovasc Electrophysiol 2011; 22:748-755.
Gerstenfeld EP, Dixit S, Bala R, Callans DJ, Lin D, Sauer W, Garcia F, Cooper J, Russo AM, Marchlinski FE. Surface electrocardiogram characteristics of atrial tachycardias occurring after pulmonary vein isolation. Heart Rhythm 2007; 4:1136-1143.
Markowitz SM, Brodman RF, Stein KM, Mittal S, Slotwiner DJ, Iwai S, Das MK, Lerman BB. Lesional tachycardias related to mitral valve surgery. J Am Coll Cardiol 2002; 39:1973-1983.
Takahashi K, Miyauchi Y, Hayashi M, Iwasaki Y-k, Yodogawa K, Tsuboi I, Hayashi H, Oka E, Ito Hagiwara K, Fujimoto Y, Shimizu W. Mechanisms of postoperative atrial tachycardia following biatrial surgical ablation of atrial fibrillation in relation to the surgical lesion sets. Heart Rhythm 2016; 13:1059-1065.
Zhang J, Tang C, Zhang Y, Han H, Li Z, Su XI. Electroanatomic characterization and ablation outcome of nonlesion related left atrial macroreentrant tachycardia in patients without obvious structural heart disease. J Cardiovasc Electrophysiol 2013; 24:53-59.
Fukamizu S, Sakurada H, Hayashi T, Hojo R, Komiyama K, Tanabe Y, Tejima T, Nishizaki M, Kobayashi Y, Hiraoka M. Macroreentrant atrial tachycardia in patients without previous atrial surgery or catheter ablation: Clinical and electrophysiological characteristics of scar-related left atrial anterior wall reentry. J Cardiovasc Electrophysiol 2013; 24:404-412.
Marrouche NF, Natale A, Wazni OM, Cheng J, Yang Y, Pollack H, Verma A, Ursell P, Scheinman MM. Left septal atrial flutter: Electrophysiology, anatomy, and results of ablation. Circulation 2004; 109:2440-2447.
Sawhney N, Anand K, Robertson CE, Wurdeman T, Anousheh R, Feld GK. Recovery of mitral isthmus conduction leads to the development of macroreentrant tachycardia after left atrial linear ablation for atrial fibrillation. Circ Arrhythm Electrophysiol 2011; 4:832-837.
Miyazaki S, Shah AJ, Hocini M, Haïssaguerre M, Jaïs P. Recurrent spontaneous clinical perimitral atrial tachycardia in the context of atrial fibrillation ablation. Heart Rhythm 2015; 12:104-110.
Ammar S, Luik A, Hessling G, Bruhm A, Reents T, Semmler V, Buiatti A, Kathan S, Hofmann M, Kolb C, Schmitt C, Deisenhofer I. Ablation of perimitral flutter: Acute and long-term success of the modified anterior line. Europace 2015; 17:447-452.
Chugh A, Oral H, Lemola K, Hall B, Cheung P, Good E, Tamirisa K, Han J, Bogun F, Pelosi F, Morady F. Prevalence, mechanisms, and clinical significance of macroreentrant atrial tachycardia during and following left atrial ablation for atrial fibrillation. Heart Rhythm 2005; 2:464-471.
Nikolaidou T, Aslanidi OV, Zhang H, Efimov IR. Structure-function relationship in the sinus and atrioventricular nodes. Pediatr Cardiol 2012; 33:890-899.
Hucker WJ, McCain ML, Laughner JI, Iaizzo PA, Efimov IR. Connexin 43 expression delineates two discrete pathways in the human atrioventricular junction. Anat Rec (Hoboken) 2008; 291:204-215.
Katritsis DG, Efimov IR. Cardiac connexin genotyping for identification of the circuit of atrioventricular nodal re-entrant tachycardia. Europace 2018; 21:190-191.
Katritsis DG, Becker AE, Ellenbogen KA, Giazitzoglou E, Korovesis S, Camm AJ. Effect of slow pathway ablation in atrioventricular nodal reentrant tachycardia on the electrophysiologic characteristics of the inferior atrial inputs to the human atrioventricular node. Am J Cardiol 2006; 97:860-865.
Katritsis DG, Ellenbogen KA, Becker AE, Camm AJ. Retrograde slow pathway conduction in patients with atrioventricular nodal re-entrant tachycardia. Europace 2007; 9:458-465.
Katritsis DG, Sepahpour A, Marine JE, Katritsis GD, Tanawuttiwat T, Calkins H, Rowland E, Josephson ME. Atypical atrioventricular nodal reentrant tachycardia: Prevalence, electrophysiologic characteristics, and tachycardia circuit. Europace 2015; 17:1099-1106.
Pentinga ML, Meeder JG, Crijns HJGM, de Muinck ED, Wiesfeld ACP, Lie KI. Late onset atrioventricular nodal tachycardia. Int J Cardiol 1993; 38:293-298.
D'Este D, Zoppo F, Bertaglia E, Zerbo F, Picciolo A, Scarabeo V, Pascotto A, Pascotto P. Long-term outcome of patients with atrioventricular node reentrant tachycardia. Int J Cardiol 2007; 115:350-353.
Sauer WH, Alonso C, Zado E, Cooper JM, Lin D, Dixit S, Russo A, Verdino R, Ji S, Gerstenfeld EP, Callans DJ, Marchlinski FE. Atrioventricular nodal reentrant tachycardia in patients referred for atrial fibrillation ablation: Response to ablation that incorporates slow-pathway modification. Circulation 2006; 114:191-195.
Michowitz Y, Anis-Heusler A, Reinstein E, Tovia-Brodie O, Glick A, Belhassen B. Familial occurrence of atrioventricular nodal reentrant tachycardia. Circ Arrhythm Electrophysiol 2017; 10:e004680.
Katritsis DG, Josephson ME. Classification, electrophysiological features and therapy of atrioventricular nodal reentrant tachycardia. Arrhythm Electrophysiol Rev 2016; 5:130-135.
Katritsis DG, Camm AJ. Atrioventricular nodal reentrant tachycardia. Circulation 2010; 122:831-840.
Katritsis DG, Josephson ME. Classification of electrophysiological types of atrioventricular nodal re-entrant tachycardia: A reappraisal. Europace 2013; 15:1231-1240.
Yamabe H, Tanaka Y, Morihisa K, Uemura T, Enomoto K, Kawano H, Ogawa H. Analysis of the anatomical tachycardia circuit in verapamil-sensitive atrial tachycardia originating from the vicinity of the atrioventricular node. Circ Arrhythm Electrophysiol 2010; 3:54-62.
Engelstein ED, Stein KM, Markowitz SM, Lerman BB. Posterior fast atrioventricular node pathways: Implications for radiofrequency catheter ablation of atrioventricular node reentrant tachycardia. J Am Coll Cardiol 1996; 27:1098-1105.
Katritsis DG, Ellenbogen KA, Becker AE. Atrial activation during atrioventricular nodal reentrant tachycardia: Studies on retrograde fast pathway conduction. Heart Rhythm 2006; 3:993-1000.
Nam G-B, Rhee K-S, Kim JUN, Choi K-J, Kim Y-H. Left atrionodal connections in typical and atypical atrioventricular nodal reentrant tachycardias: Activation sequence in the coronary sinus and results of radiofrequency catheter ablation. J Cardiovasc Electrophysiol 2006; 17:171-177.
Katritsis DG, Marine JE, Latchamsetty R, Zografos T, Tanawuttiwat T, Sheldon SH, Buxton AE, Calkins H, Morady F, Josephson ME. Coexistent types of atrioventricular nodal re-entrant tachycardia. Implications for the tachycardia circuit. Circ Arrhythm Electrophysiol 2015; 8:1189-1193.
Miljoen H, Ector J, Garweg C, Saenen J, Huybrechts W, Sarkozy A, Willems R, Heidbuchel H. Differential presentation of atrioventricular nodal re-entrant tachycardia in athletes and non-athletes. Europace 2019; 21:944-949.
Nawata H, Yamamoto N, Hirao K, Miyasaka N, Kawara T, Hiejima K, Harada T, Suzuki F. Heterogeneity of anterograde fast-pathway and retrograde slowpathway conduction patterns in patients with the fast-slow form of atrioventricular nodal reentrant tachycardia: Electrophysiologic and electrocardiographic considerations. J Am Coll Cardiol 1998; 32:1731-1740.
Hwang C, Martin DJ, Goodman JS, Gang ES, Mandel WJ, Swerdlow CD, Peter CT, Chen P-S. Atypical atrioventricular node reciprocating tachycardia masquerading as tachycardia using a left-sided accessory pathway. J Am Coll Cardiol 1997; 30:218-225.
Sakabe K, Wakatsuki T, Fujinaga H, Oishi Y, Ikata J, Toyoshima T, Hiura N, Nishikado A, Oki T, Ito S. Patient with atrioventricular node reentrant tachycardia with eccentric retrograde left-sided activation: Treatment with radiofrequency catheter ablation. Jpn Heart J 2000; 41:227-234.
Vijayaraman P, Kok LC, Rhee B, Ellenbogen KA. Unusual variant of atrioventricular nodal reentrant tachycardia. Heart Rhythm 2005; 2:100-102.
Heidbuchel H, Jackman WM. Characterization of subforms of AV nodal reentrant tachycardia. Europace 2004; 6:316-329.
Katritsis DG, Zografos T, Katritsis GD, Giazitzoglou E, Vachliotis V, Paxinos G, Camm AJ, Josephson ME. Catheter ablation vs. antiarrhythmic drug therapy in patients with symptomatic atrioventricular nodal re-entrant tachycardia: A randomized, controlled trial. Europace 2017; 19:602-606.
Katritsis DG, John RM, Latchamsetty R, Muthalaly RG, Zografos T, Katritsis GD, Stevenson WG, Efimov IR, Morady F. Left septal slow pathway ablation for atrioventricular nodal reentrant tachycardia. Circ Arrhythm Electrophysiol 2018; 11:e005907.
Katritsis DG, Marine JE, Contreras FM, Fujii A, Latchamsetty R, Siontis KC, Katritsis GD, Zografos T, John RM, Epstein LM, Michaud GF, Anter E, Sepahpour A, Rowland E, Buxton AE, Calkins H, Morady F, Stevenson WG, Josephson ME. Catheter ablation of atypical atrioventricular nodal reentrant tachycardia. Circulation 2016; 134:1655-1663.
Stavrakis S, Jackman WM, Lockwood D, Nakagawa H, Beckman K, Elkholey K, Wang Z, Po SS. Slow/fast atrioventricular nodal reentrant tachycardia using the inferolateral left atrial slow pathway. Circ Arrhythm Electrophysiol 2018; 11:e006631.
Rinkenberger RL, Prystowsky EN, Heger JJ, Troup PJ, Jackman WM, Zipes DP. Effects of intravenous and chronic oral verapamil administration in patients with supraventricular tachyarrhythmias. Circulation 1980; 62:996-1010.
Winniford MD, Fulton KL, Hills LD. Long-term therapy of paroxysmal supraventricular tachycardia: A randomized, double-blind comparison of digoxin, propranolol and verapamil. Am J Cardiol 1984; 54:1138-1139.
Alboni P, Tomasi C, Menozzi C, Bottoni N, Paparella N, Fuca G, Brignole M, Cappato R. Efficacy and safety of out-of-hospital self-administered single-dose oral drug treatment in the management of infrequent, well-tolerated paroxysmal supraventricular tachycardia. J Am Coll Cardiol 2001; 37:548-553.
Yeh SJ, Lin FC, Chou YY, Hung JS, Wu D. Termination of paroxysmal supraventricular tachycardia with a single oral dose of diltiazem and propranolol. Circulation 1985; 71:104-109.
Musto B, Cavallaro C, Musto A, D'Onofrio A, Belli A, De Vincentis L. Flecainide single oral dose for management of paroxysmal supraventricular tachycardia in children and young adults. Am Heart J 1992; 124:110-115.
Goldberg AS, Bathina MN, Mickelsen S, Nawman R, West G, Kusumoto FM. Long-term outcomes on quality-of-life and health care costs in patients with supraventricular tachycardia (radiofrequency catheter ablation versus medical therapy). Am J Cardiol 2002; 89:1120-1123.
Larson MS, McDonald K, Young C, Sung R, Hlatky MA. Quality of life before and after radiofrequency catheter ablation in patients with drug refractory atrioventricular nodal reentrant tachycardia. Am J Cardiol 1999; 84: 471-473.
Bathina M, Mickelsen S, Brooks C, Jaramillo J, Hepton T, Kusumoto F. Radiofrequency catheter ablation versus medical therapy for initial treatment of supraventricular tachycardia and its impact on quality of life and healthcare costs. Am J Cardiol 1998; 82:589-593.
Cheng CF, Sanders GD, Hlatky MA, Heidenreich P, McDonald KM, Lee BK, Larson MS, Owens DK. Cost-effectiveness of radiofrequency ablation for supraventricular tachycardia. Ann Intern Med 2000; 133:864-876.
Kalbfleisch SJ, Calkins H, Langberg JJ, El-Atassi R, Leon A, Borganelli M, Morady F. Comparison of the cost of radiofrequency catheter modification of the atrioventricular node and medical therapy for drug-refractory atrioventricular node reentrant tachycardia. J Am Coll Cardiol 1992; 19:1583-1587.
Kalbfleisch SJ, Strickberger SA, Williamson B, Vorperian VR, Man C, Hummel JD, Langberg JJ, Morady F. Randomized comparison of anatomic and electrogram mapping approaches to ablation of the slow pathway of atrioventricular node reentrant tachycardia. J Am Coll Cardiol 1994; 23:716-723.
Katritsis DG, Giazitzoglou E, Zografos T, Ellenbogen KA, Camm AJ. An approach to left septal slow pathway ablation. J Interv Card Electrophysiol 2011; 30:73-79.
Morady F. Catheter ablation of supraventricular arrhythmias: State of the art. Heart Rhythm 2004; 1:C67-C84.
Van Hare GF, Javitz H, Carmelli D, Saul JP, Tanel RE, Fischbach PS, Kanter RJ, Schaffer M, Dunnigan A, Colan S, Serwer G; Pediatric Electrophysiology Society. Prospective assessment after pediatric cardiac ablation: Demographics, medical profiles, and initial outcomes. J Cardiovasc Electrophysiol 2004; 15:759-770.
Katritsis DG. Catheter ablation of atrioventricular nodal re-entrant tachycardia: Facts and fiction. Arrhythm Electrophysiol Rev 2018; 7:230-231.
Chen H, Shehata M, Ma W, Xu J, Cao J, Cingolani E, Swerdlow C, Chen M, Chugh SS, Wang X. Atrioventricular block during slow pathway ablation: Entirely preventable?. Circ Arrhythm Electrophysiol 2015; 8:739-744.
Papagiannis J, Beissel DJ, Krause U, Cabrera M, Telishevska M, Seslar S, Johnsrude C, Anderson C, Tisma-Dupanovic S, Connelly D, Avramidis D, Carter C, Kornyei L, Law I, Von Bergen N, Janusek J, Silva J, Rosenthal E, Willcox M, Kubus P, Hessling G, Paul T; Paediatric and Congenital Electrophysiology Society. Atrioventricular nodal reentrant tachycardia in patients with congenital heart disease. Outcome after catheter ablation. Circ Arrhythm Electrophysiol 2017; 10:e004869.
Backhoff D, Klehs S, Müller MJ, Schneider HE, Kriebel T, Paul T, Krause U. Long-term follow-up after catheter ablation of atrioventricular nodal reentrant tachycardia in children. Circ Arrhythm Electrophysiol 2016; 9:e004264.
Skeberis V, Simonis F, Tsakonas K, Celiker Alp AY, Andries E, Brugada P. Inappropriate sinus tachycardia following radiofrequency ablation of AV nodal tachycardia: Incidence and clinical significance. Pacing Clin Electrophysiol 1994; 17:924-927.
Rostock T, Risius T, Ventura R, Klemm HU, Weiss C, Keitel A, Meinertz T, Willems S. Efficacy and safety of radiofrequency catheter ablation of atrioventricular nodal reentrant tachycardia in the elderly. J Cardiovasc Electrophysiol 2005; 16:608-610.
Li YG, Gronefeld G, Bender B, Machura C, Hohnloser SH. Risk of development of delayed atrioventricular block after slow pathway modification in patients with atrioventricular nodal reentrant tachycardia and a pre-existing prolonged PR interval. Eur Heart J 2001; 22:89-95.
Deisenhofer I, Zrenner B, Yin Y-h, Pitschner H-F, Kuniss M, Grossmann G, Stiller S, Luik A, Veltmann C, Frank J, Linner J, Estner HL, Pflaumer A, Wu J, von Bary C, Ucer E, Reents T, Tzeis S, Fichtner S, Kathan S, Karch MR, Jilek C, Ammar S, Kolb C, Liu Z-C, Haller B, Schmitt C, Hessling G. Cryoablation versus radiofrequency energy for the ablation of atrioventricular nodal reentrant tachycardia (the CYRANO Study): Results from a large multicenter prospective randomized trial. Circulation 2010; 122:2239-2245.
Hanninen M, Yeung-Lai-Wah N, Massel D, Gula LJ, Skanes AC, Yee R, Klein GJ, Manlucu J, Leong-Sit P. Cryoablation versus RF ablation for AVNRT: A meta-analysis and systematic review. J Cardiovasc Electrophysiol 2013; 24:1354-1360.
Matta M, Anselmino M, Scaglione M, Vitolo M, Ferraris F, Di Donna P, Caponi D, Castagno D, Gaita F. Cooling dynamics: A new predictor of long-term efficacy of atrioventricular nodal reentrant tachycardia cryoablation. J Interv Card Electrophysiol 2017; 48:333-341.
Pieragnoli P, Paoletti Perini A, Checchi L, Carrassa G, Giomi A, Carrai P, Michelucci A, Padeletti L, Ricciardi G. Cryoablation of typical AVNRT: Younger age and administration of bonus ablation favor long-term success. Heart Rhythm 2015; 12:2125-2131.
Enriquez A, Ellenbogen KA, Boles U, Baranchuk A. Atrioventricular nodal reentrant tachycardia in implantable cardioverter defibrillators: Diagnosis and troubleshooting. J Cardiovasc Electrophysiol 2015; 26:1282-1288.
Walsh EP, Saul JP, Sholler GF, Triedman JK, Jonas RA, Mayer JE, Wessel DL. Evaluation of a staged treatment protocol for rapid automatic junctional tachycardia after operation for congenital heart disease. J Am Coll Cardiol 1997; 29:1046-1053.
Cools E, Missant C. Junctional ectopic tachycardia after congenital heart surgery. Acta Anaesthesiol Belg 2014; 65:1-8.
Collins KK, Van Hare GF, Kertesz NJ, Law IH, Bar-Cohen Y, Dubin AM, Etheridge SP, Berul CI, Avari JN, Tuzcu V, Sreeram N, Schaffer MS, Fournier A, Sanatani S, Snyder CS, Smith RT Jr, Arabia L, Hamilton R, Chun T, Liberman L, Kakavand B, Paul T, Tanel RE. Pediatric nonpost-operative junctional ectopic tachycardia medical management and interventional therapies. J Am Coll Cardiol 2009; 53:690-697.
Hamdan M, Van Hare GF, Fisher W, Gonzalez R, Dorostkar P, Lee R, Lesh M, Saxon L, Kalman J, Scheinman M. Selective catheter ablation of the tachycardia focus in patients with nonreentrant junctional tachycardia. Am J Cardiol 1996; 78:1292-1297.
Ruder MA, Davis JC, Eldar M, Abbott JA, Griffin JC, Seger JJ, Scheinman MM. Clinical and electrophysiologic characterization of automatic junctional tachycardia in adults. Circulation 1986; 73:930-937.
Fishenfeld J, Desser KB, Benchimol A. Non-paroxysmal A-V junctional tachycardia associated with acute myocardial infarction. Am Heart J 1973; 86:754-758.
Kumagai K, Yamato H, Yamanouchi Y, Matsuo K, Tashiro N, Hiroki T, Arakawa K. Automatic junctional tachycardia in an adult. Clinical Cardiology 1990; 13:813-816.
Cook JR, Steinberg JS. An incessant form of junctional ectopic tachycardia in an adult responsive to a class 1C agent. Am Heart J 1991; 122:1487-1489.
Amrousy DE, Elshehaby W, Feky WE, Elshmaa NS. Safety and efficacy of prophylactic amiodarone in preventing early junctional ectopic tachycardia (JET) in children after cardiac surgery and determination of its risk factor. Pediatr Cardiol 2016; 37:734-739.
Entenmann A, Michel M, Herberg U, Haas N, Kumpf M, Gass M, Egender F, Gebauer R. Management of postoperative junctional ectopic tachycardia in pediatric patients: A survey of 30 centers in Germany, Austria, and Switzerland. Eur J Pediatr 2017; 176:1217-1226.
Raja P, Hawker RE, Chaikitpinyo A, Cooper SG, Lau KC, Nunn GR, Cartmill TB, Sholler GF. Amiodarone management of junctional ectopic tachycardia after cardiac surgery in children. Br Heart J 1994; 72:261-265.
Sarubbi B, Musto B, Ducceschi V, D'Onofrio A, Cavallaro C, Vecchione F, Musto C, Calabro R. Congenital junctional ectopic tachycardia in children and adolescents: A 20 year experience based study. Heart 2002; 88:188-190.
Dieks J-K, Klehs S, Müller MJ, Paul T, Krause U. Adjunctive ivabradine in combination with amiodarone: A novel therapy for pediatric congenital junctional ectopic tachycardia. Heart Rhythm 2016; 13:1297-1302.
Al-Ghamdi S, Al-Fayyadh MI, Hamilton RM. Potential new indication for ivabradine: Treatment of a patient with congenital junctional ectopic tachycardia. J Cardiovasc Electrophysiol 2013; 24:822-824.
Kuck K-H, Kunze K-P, Schlüter M, Duckeck W. Encainide versus flecainide for chronic atrial and junctional ectopic tachycardia. Am J Cardiol 1988; 62:L37-L44.
Paul T, Reimer A, Janousek J, Kallfelz H-C. Efficacy and safety of propafenone in congenital junctional ectopic tachycardia. J Am Coll Cardiol 1992; 20:911-914.
Hamdan MH, Badhwar N, Scheinman MM. Role of invasive electrophysiologic testing in the evaluation and management of adult patients with focal junctional tachycardia. Card Electrophysiol Rev 2002; 6:431-435.
Law IH, Von Bergen NH, Gingerich JC, Saarel EV, Fischbach PS, Dick M. Transcatheter cryothermal ablation of junctional ectopic tachycardia in the normal heart. Heart Rhythm 2006; 3:903-907.
Jackowska-Zduniak B, Forys U. Mathematical model of the atrioventricular nodal double response tachycardia and double-fire pathology. Math Biosci Eng 2016; 13:1143-1158.
Peiker C, Pott C, Eckardt L, Kelm M, Shin DI, Willems S, Meyer C. Dual atrioventricular nodal non-re-entrant tachycardia. Europace 2016; 18:332-339.
Yokoshiki H, Sasaki K, Shimokawa J, Sakurai M, Tsutsui H. Nonreentrant atrioventricular nodal tachycardia due to triple nodal pathways manifested by radiofrequency ablation at coronary sinus ostium. J Electrocardiol 2006; 39:395-399.
Itagaki T, Ohnishi Y, Inoue T, Yokoyama M. Linking phenomenon in dual atrioventricular nodal pathways. Jpn Circ J 2001; 65:937-940.
Arena G, Bongiorni MG, Soldati E, Gherarducci G, Mariani M. Incessant nonreentrant atrioventricular nodal tachycardia due to multiple nodal pathways treated by radiofrequency ablation of the slow pathways. J Cardiovasc Electrophysiol 1999; 10:1636-1642.
Wang NC. Dual atrioventricular nodal nonreentrant tachycardia: A systematic review. Pacing Clin Electrophysiol 2011; 34:1671-1681.
Ho SY. Accessory atrioventricular pathways: Getting to the origins. Circulation 2008; 117:1502-1504.
Jackman WM, Wang XZ, Friday KJ, Roman CA, Moulton KP, Beckman KJ, McClelland JH, Twidale N, Hazlitt HA, Prior MI, Margolis PD, Calame JD, Overholt ED, Lazzara R. Catheter ablation of accessory atrioventricular pathways (Wolff-Parkinson-White syndrome) by radiofrequency current. N Engl J Med 1991; 324:1605-1611.
Katritsis D, Bashir Y, Heald S, Poloniecki J, Ward DE. Radiofrequency ablation of accessory pathways: Implications of accumulated experience and time dedicated to procedures. Eur Heart J 1994; 15:339-344.
Schluter M, Geiger M, Siebels J, Duckeck W, Kuck KH. Catheter ablation using radiofrequency current to cure symptomatic patients with tachyarrhythmias related to an accessory atrioventricular pathway. Circulation 1991; 84:1644-1661.
Liu Q, Shehata M, Lan DZ, Ehdaie A, Cingolani E, Chugh SS, Fu G, Jiang C, Wang X. Accurate localization and catheter ablation of superoparaseptal accessory pathways. Heart Rhythm 2018; 15:688-695.
Kuck KH, Friday KJ, Kunze KP, Schluter M, Lazzara R, Jackman WM. Sites of conduction block in accessory atrioventricular pathways. Basis for concealed accessory pathways. Circulation 1990; 82:407-417.
Cappato R, Schluter M, Weiss C, Antz M, Koschyk DH, Hofmann T, Kuck KH. Radiofrequency current catheter ablation of accessory atrioventricular pathways in Ebstein's anomaly. Circulation 1996; 94:376-383.
Bhatia A, Sra J, Akhtar M. Preexcitation syndromes. Curr Probl Cardiol 2016; 41:99-137.
Koneru JN, Wood MA, Ellenbogen KA. Rare forms of preexcitation: A case study and brief overview of familial forms of preexcitation. Circ Arrhythm Electrophysiol 2012; 5:e82-e87.
Xie B, Heald SC, Bashir Y, Katritsis D, Murgatroyd FD, Camm AJ, Rowland E, Ward DE. Localization of accessory pathways from the 12-lead electrocardiogram using a new algorithm. Am J Cardiol 1994; 74:161-165.
Pambrun T, El Bouazzaoui R, Combes N, Combes S, Sousa P, Le Bloa M, Massoullie G, Cheniti G, Martin R, Pillois X, Duchateau J, Sacher F, Hocini M, Jais P, Derval N, Bortone A, Boveda S, Denis A, Haissaguerre M, Albenque JP. Maximal pre-excitation based algorithm for localization of manifest accessory pathways in adults. JACC Clin Electrophysiol 2018; 4:1052-1061.
Basiouny T, de Chillou C, Fareh S, Kirkorian G, Messier M, Sadoul N, Chevalier P, Magnin-Poull I, Blankoff I, Chen J, Touboul P, Aliot E. Accuracy and limitations of published algorithms using the twelve-lead electrocardiogram to localize overt atrioventricular accessory pathways. J Cardiovasc Electrophysiol 1999; 10:1340-1349.
Packer DL, Gallagher JJ, Prystowsky EN. Physiological substrate for antidromic reciprocating tachycardia. Prerequisite characteristics of the accessory pathway and atrioventricular conduction system. Circulation 1992; 85:574-588.
Brembilla-Perrot B, Pauriah M, Sellal JM, Zinzius PY, Schwartz J, de Chillou C, Cismaru G, Beurrier D, Voilliot D, Selton O, Louis P, Andronache M, Nosu R, de la Chaise AT. Incidence and prognostic significance of spontaneous and inducible antidromic tachycardia. Europace 2013; 15:871-876.
Ceresnak SR, Tanel RE, Pass RH, Liberman L, Collins KK, Van Hare GF, Gates GJ, Dubin AM. Clinical and electrophysiologic characteristics of antidromic tachycardia in children with Wolff-Parkinson-White syndrome. Pacing Clin Electrophysiol 2012; 35:480-488.
Etheridge SP, Escudero CA, Blaufox AD, Law IH, Dechert-Crooks BE, Stephenson EA, Dubin AM, Ceresnak SR, Motonaga KS, Skinner JR, Marcondes LD, Perry JC, Collins KK, Seslar SP, Cabrera M, Uzun O, Cannon BC, Aziz PF, Kubus P, Tanel RE, Valdes SO, Sami S, Kertesz NJ, Maldonado J, Erickson C, Moore JP, Asakai H, Mill L, Abcede M, Spector ZZ, Menon S, Shwayder M, Bradley DJ, Cohen MI, Sanatani S. Life-threatening event risk in children with Wolff-Parkinson-White syndrome: A multicenter international study. JACC Clin Electrophysiol 2018; 4:433-444.
Gemma LW, Steinberg LA, Prystowsky EN, Padanilam BJ. Development of rapid preexcited ventricular response to atrial fibrillation in a patient with intermittent preexcitation. J Cardiovasc Electrophysiol 2013; 24:347-350.
Kang KT, Potts JE, Radbill AE, La Page MJ, Papagiannis J, Garnreiter JM, Kubus P, Kantoch MJ, Von Bergen NH, Fournier A, Côté J-M, Paul T, Anderson CC, Cannon BC, Miyake CY, Blaufox AD, Etheridge SP, Sanatani S. Permanent junctional reciprocating tachycardia in children: A multicenter experience. Heart Rhythm 2014; 11:1426-1432.
Moore JP, Patel PA, Shannon KM, Albers EL, Salerno JC, Stein MA, Stephenson EA, Mohan S, Shah MJ, Asakai H, Pflaumer A, Czosek RJ, Everitt MD, Garnreiter JM, McCanta AC, Papez AL, Escudero C, Sanatani S, Cain NB, Kannankeril PJ, Bratincsak A, Mandapati R, Silva JNA, Knecht KR, Balaji S. Predictors of myocardial recovery in pediatric tachycardia-induced cardiomyopathy. Heart Rhythm 2014; 11:1163-1169.
Kottkamp H, Hindricks G, Shenasa H, Chen X, Wichter T, Borggrefe M, Breithardt G. Variants of preexcitation-specialized atriofascicular pathways, nodofascicular pathways, and fasciculoventricular pathways: Electrophysiologic findings and target sites for radiofrequency catheter ablation. J Cardiovasc Electrophysiol 1996; 7:916-930.
Gandhavadi M, Sternick EB, Jackman WM, Wellens HJJ, Josephson ME. Characterization of the distal insertion of atriofascicular accessory pathways and mechanisms of QRS patterns in atriofascicular antidromic tachycardia. Heart Rhythm 2013; 10:1385-1392.
Haissaguerre M, Cauchemez B, Marcus F, Le Metayer P, Lauribe P, Poquet F, Gencel L, Clementy J. Characteristics of the ventricular insertion sites of accessory pathways with anterograde decremental conduction properties. Circulation 1995; 91:1077-1085.
Hluchy JAN, Schlegelmilch P, Schickel S, Jörger URS, Jurkovicova O, Sabin GV. Radiofrequency ablation of a concealed nodoventricular Mahaim fiber guided by a discrete potential. J Cardiovasc Electrophysiol 1999; 10:603-610.
Katritsis DG, Wellens HJ, Josephson ME. Mahaim accessory pathways. Arrhythm Electrophysiol Rev 2017; 6:29-32.
de Alencar Neto JN, Ramalho de Moraes SR, Back Sternick E, Wellens HJJ. Atypical bypass tracts: Can they be recognized during sinus rhythm?. Europace 2019; 21:208-218.
Francia P, Pittalis MC, Ali H, Cappato R. Electrophysiological study and catheter ablation of a Mahaim fibre located at the mitral annulus-aorta junction. J Interv Card Electrophysiol 2008; 23:153-157.
Johnson CT, Brooks C, Jaramillo J, Mickelsen S, Kusumoto FM. A left free-wall, decrementally conducting, atrioventricular (Mahaim) fiber: Diagnosis at electrophysiological study and radiofrequency catheter ablation guided by direct recording of a Mahaim potential. Pacing Clin Electrophysiol 1997; 20:2486-2488.
Yamabe H, Okumura K, Minoda K, Yasue H. Nodoventricular Mahaim fiber connecting to the left ventricle. Am Heart J 1991; 122:232-234.
Han FT, Riles EM, Badhwar N, Scheinman MM. Clinical features and sites of ablation for patients with incessant supraventricular tachycardia from concealed nodofascicular and nodoventricular tachycardias. JACC Clin Electrophysiol 2017; 3:1547-1556.
Hamer A, Peter T, Platt M, Mandel WJ. Effects of verapamil on supraventricular tachycardia in patients with overt and concealed Wolff-Parkinson-White syndrome. Am Heart J 1981; 101:600-612.
Huycke EC, Sung RJ, Dias VC, Milstein S, Hariman RJ, Platia EV. Intravenous diltiazem for termination of reentrant supraventricular tachycardia: A placebocontrolled, randomized, double-blind, multicenter study. J Am Coll Cardiol 1989; 13:538-544.
Glatter KA, Dorostkar PC, Yang Y, Lee RJ, Van Hare GF, Keung E, Modin G, Scheinman MM. Electrophysiological effects of ibutilide in patients with accessory pathways. Circulation 2001; 104:1933-1939.
Sellers TD Jr, Campbell RW, Bashore TM, Gallagher JJ. Effects of procainamide and quinidine sulfate in the Wolff-Parkinson-White syndrome. Circulation 1977; 55:15-22.
Wellens HJJ, Brugada P, Abdollah H. Effect of amiodarone in paroxysmal supraventricular tachycardia with or without Wolff-Parkinson-White syndrome. Am Heart J 1983; 106:876-880.
Holt P, Crick JCP, Davies DW, Curry P. Intravenous amiodarone in the acute termination of supraventricular arrhythmias. Int J Cardiol 1985; 8:67-76.
Levy S, Ricard P. Using the right drug: A treatment algorithm for regular supraventricular tachycardias. Eur Heart J 1997; 18:27-32.
Fujimura O, Kuo C-S, Smith BA. Pre-excited RR intervals during atrial fibrillation in the Wolff-Parkinson-White syndrome: Influence of the atrioventricular node refractory period. J Am Coll Cardiol 1991; 18:1722-1726.
Morady F, DiCarlo LA Jr, Baerman JM, De Buitleir M. Effect of propranolol on ventricular rate during atrial fibrillation in the Wolff-Parkinson-White syndrome. Pacing Clin Electrophysiol 1987; 10:492-496.
Sellers TD Jr, Bashore TM, Gallagher JJ. Digitalis in the pre-excitation syndrome. Analysis during atrial fibrillation. Circulation 1977; 56:260-267.
Ludmer PL, McGowan NE, Antman EM, Friedman PL. Efficacy of propafenone in Wolff-Parkinson-White syndrome: Electrophysiologic findings and long-term follow-up. J Am Coll Cardiol 1987; 9:1357-1363.
Boahene KA, Klein GJ, Yee R, Sharma AD, Fujimura O. Termination of acute atrial fibrillation in the Wolff-Parkinson-White syndrome by procainamide and propafenone: Importance of atrial fibrillatory cycle length. J Am Coll Cardiol 1990; 16:1408-1414.
Crijns HJGM, den Heijer P, van Wijk LM, Lie KI. Successful use of flecainide in atrial fibrillation with rapid ventricular rate in the Wolff-Parkinson-White syndrome. Am Heart J 1988; 115:1317-1321.
Boriani G, Biffi M, Frabetti L, Azzolini U, Sabbatani P, Bronzetti G, Capucci A, Magnani B. Ventricular fibrillation after intravenous amiodarone in Wolff-Parkinson-White syndrome with atrial fibrillation. Am Heart J 1996; 131:1214-1216.
Schützenberger W, Leisch F, Gmeiner R. Enhanced accessory pathway conduction following intravenous amiodarone in atrial fibrillation. A case report. Int J Cardiol 1987; 16:93-95.
Tijunelis MA, Herbert ME. Myth: Intravenous amiodarone is safe in patients with atrial fibrillation and Wolff-Parkinson-White syndrome in the emergency department. CJEM 2005; 7:262-265.
Kappenberger LJ, Fromer MA, Steinbrunn W, Shenasa M. Efficacy of amiodarone in the Wolff-Parkinson-White syndrome with rapid ventricular response via accessory pathway during atrial fibrillation. Am J Cardiol 1984; 54:330-335.
Simonian SM, Lotfipour S, Wall C, Langdorf MI. Challenging the superiority of amiodarone for rate control in Wolff-Parkinson-White and atrial fibrillation. Intern Emerg Med 2010; 5:421-426.
Kim SS, Lal R, Ruffy R. Treatment of paroxysmal reentrant supraventricular tachycardia with flecainide acetate. Am J Cardiol 1986; 58:80-85.
Bravo L, Atienza F, Eidelman G, Avila P, Pelliza M, Castellanos E, Loughlin G, Datino T, Torrecilla EG, Almendral J, Sanchez PL, Arenal A, Martínez-Alzamora N, Fernandez-Avilés F. Safety and efficacy of cryoablation vs. radiofrequency ablation of septal accessory pathways: Systematic review of the literature and meta-analyses. Europace 2017; 20:1334-1342.
Pappone C, Vicedomini G, Manguso F, Saviano M, Baldi M, Pappone A, Ciaccio C, Giannelli L, Ionescu B, Petretta A, Vitale R, Cuko A, Calovic Z, Fundaliotis A, Moscatiello M, Tavazzi L, Santinelli V. Wolff-Parkinson-White syndrome in the era of catheter ablation: Insights from a registry study of 2169 patients. Circulation 2014; 130:811-819.
Xue Y, Zhan X, Wu S, Wang H, Liu Y, Liao Z, Deng H, Duan X, Zeng S, Liang D, Elvan A, Fang X, Liao H, Ramdat Misier AR, Smit JJJ, Metzner A, Heeger C-H, Liu F, Wang F, Zhang Z, Kuck K-H, Yen Ho S, Ouyang F. Experimental, pathologic, and clinical findings of radiofrequency catheter ablation of para-Hisian region from the right ventricle in dogs and humans. Circ Arrhythm Electrophysiol 2017; 10:e005207.
Katritsis D, Giazitzoglou E, Korovesis S, Zambartas C. Comparison of the transseptal approach to the transaortic approach for ablation of left-sided accessory pathways in patients with Wolff-Parkinson-White syndrome. Am J Cardiol 2003; 91:610-613.
Mauritson DR, Winniford MD, Walker W, Rude RE, Cary JR, Hillis L. Oral verapamil for paroxysmal supraventricular tachycardia: A long-term, double-blind randomized trial. Ann Intern Med 1982; 96:409-412.
Sakurai M, Yasuda H, Kato N, Nomura A, Fujita M, Nishino T, Fujita K, Koike Y, Saito H. Acute and chronic effects of verapamil in patients with paroxysmal supraventricular tachycardia. Am Heart J 1983; 105:619-628.
Vassiliadis I, Papoutsakis P, Kallikazaros I, Stefanadis C. Propafenone in the prevention of non-ventricular arrhythmias associated with the Wolff-Parkinson-White syndrome. Int J Cardiol 1990; 27:63-70.
Cockrell JL, Scheinman MM, Titus C, Helmy I, Langberg JJ, Lee MA, Griffin JC. Safety and efficacy of oral flecainide therapy in patients with atrioventricular reentrant tachycardia. Ann Intern Med 1991; 114:189-194.
Schützenberger W, Leisch F, Gmeiner R. Enhanced accessory pathway conduction following intravenous amiodarone in atrial fibrillation. A case report. Int J Cardiol 1987; 16:93-95.
Marazzato J, Fonte G, Marazzi R, Doni LA, Mitacchione G, Vilotta M, De Ponti R. Efficacy and safety of cryoablation of para-Hisian and mid-septal accessory pathways using a specific protocol: Single-center experience in consecutive patients. J Interv Card Electrophysiol 2019; 55:47-54.
Manolis AS, Wang PJ, Estes NA III. Radiofrequency ablation of left-sided accessory pathways: Transaortic versus transseptal approach. Am Heart J 1994; 128:896-902.
Obeyesekere MN, Leong-Sit P, Massel D, Manlucu J, Modi S, Krahn AD, Skanes AC, Yee R, Gula LJ, Klein GJ. Risk of arrhythmia and sudden death in patients with asymptomatic preexcitation. A meta-analysis. Circulation 2012; 125:2308-2315.
Santinelli V, Radinovic A, Manguso F, Vicedomini G, Gulletta S, Paglino G, Mazzone P, Ciconte G, Sacchi S, Sala S, Pappone C. The natural history of asymptomatic ventricular pre-excitation: A long-term prospective follow-up study of 184 asymptomatic children. J Am Coll Cardiol 2009; 53:275-280.
Klein GJ, Bashore TM, Sellers TD, Pritchett ELC, Smith WM, Gallagher JJ. Ventricular fibrillation in the Wolff-Parkinson-White syndrome. N Engl J Med 1979; 301:1080-1085.
Kubus P, Vít P, Gebauer RA, Materna O, Janousek J. Electrophysiologic profile and results of invasive risk stratification in asymptomatic children and adolescents with the Wolff-Parkinson-White electrocardiographic pattern. Circ Arrhythm Electrophysiol 2014; 7:218-223.
Pappone C, Santinelli V, Manguso F, Augello G, Santinelli O, Vicedomini G, Gulletta S, Mazzone P, Tortoriello V, Pappone A, Dicandia C, Rosanio S. A randomized study of prophylactic catheter ablation in asymptomatic patients with the Wolff-Parkinson-White Syndrome. N Engl J Med 2003; 349:1803-1811.
Santinelli V, Radinovic A, Manguso F, Vicedomini G, Ciconte G, Gulletta S, Paglino G, Sacchi S, Sala S, Ciaccio C, Pappone C. Asymptomatic ventricular preexcitation: A long-term prospective follow-up study of 293 adult patients. Circ Arrhythm Electrophysiol 2009; 2:102-107.
Montoya PT, Brugada P, Smeets J, Talajic M, Della Bella P, Lezaun R, Dool AVD, Wellens HJJ, De Luna AB, Oter R, Breithardt G, Borggrefe M, Klein H, Kuck KH, Kunze K, Coumel P, Leclercq JF, Chouty F, Frank R, Fontanine G. Ventricular fibrillation in the Wolff-Parkinson-White syndrome. Eur Heart J 1991; 12:144-150.
Pappone C, Vicedomini G, Manguso F, Baldi M, Pappone A, Petretta A, Vitale R, Saviano M, Ciaccio C, Giannelli L, Calovic Z, Tavazzi L, Santinelli V. Risk of malignant arrhythmias in initially symptomatic patients with Wolff-Parkinson-White syndrome: Results of a prospective long-term electrophysiological follow-up study. Circulation 2012; 125:661-668.
Leitch JW, Klein GJ, Yee R, Murdock C. Prognostic value of electrophysiology testing in asymptomatic patients with Wolff-Parkinson-White pattern. Circulation 1990; 82:1718-1723.
Rinne C, Klein GJ, Sharma AD, Yee R, Milstein S, Rattes MF. Relation between clinical presentation and induced arrhythmias in the Wolff-Parkinson-White syndrome. Am J Cardiol 1987; 60:576-579.
Sharma AD, Yee R, Guiraudon G, Klein GJ. Sensitivity and specificity of invasive and noninvasive testing for risk of sudden death in Wolff-Parkinson-White syndrome. J Am Coll Cardiol 1987; 10:373-381.
Moore JP, Kannankeril PJ, Fish FA. Isoproterenol administration during general anesthesia for the evaluation of children with ventricular preexcitation. Circ Arrhythm Electrophysiol 2011; 4:73-78.
Daubert C, Ollitrault J, Descaves C, Mabo P, Ritter P, Gouffault J. Failure of the exercise test to predict the anterograde refractory period of the accessory pathway in Wolff Parkinson White syndrome. Pacing Clin Electrophysiol 1988; 11:1130-1138.
Wackel P, Irving C, Webber S, Beerman L, Arora G. Risk stratification in Wolff-Parkinson-White syndrome: The correlation between noninvasive and invasive testing in pediatric patients. Pacing Clin Electrophysiol 2012; 35:1451-1457.
Gaita F, Giustetto C, Riccardi R, Mangiardi L, Brusca A. Stress and pharmacologic tests as methods to identify patients with Wolff-Parkinson-White syndrome at risk of sudden death. Am J Cardiol 1989; 64:487-490.
PediatricCongenital Electrophysiology S, Heart Rhythm S, American College of Cardiology F, American Heart A, American Academy of P, Canadian Heart Rhythm SCohen MI, Triedman JK, Cannon BC, Davis AM, Drago F, Janousek J, Klein GJ, Law IH, Morady FJ, Paul T, Perry JC, Sanatani S, Tanel RE. PACES/HRS expert consensus statement on the management of the asymptomatic young patient with a Wolff-Parkinson-White (WPW, ventricular preexcitation) electrocardiographic pattern: Developed in partnership between the Pediatric and Congenital Electrophysiology Society (PACES) and the Heart Rhythm Society (HRS). Endorsed by the governing bodies of PACES, HRS, the American College of Cardiology Foundation (ACCF), the American Heart Association (AHA), the American Academy of Pediatrics (AAP), and the Canadian Heart Rhythm Society (CHRS). Heart Rhythm 2012; 9:1006-1024.
Jastrzebski M, Kukla P, Pitak M, Rudzinski A, Baranchuk A, Czarnecka D. Intermittent preexcitation indicates "a low-risk" accessory pathway: Time for a paradigm shift?. Ann Noninvasive Electrocardiol 2017; 22:e12464.
Kiger ME, McCanta AC, Tong S, Schaffer M, Runciman M, Collins KK. Intermittent versus persistent Wolff-Parkinson-White syndrome in children: Electrophysiologic properties and clinical outcomes. Pacing Clin Electrophysiol 2016; 39:14-20.
Cohen M. Intermittent preexcitation: Should we rethink the current guidelines?. Pacing Clin Electrophysiol 2016; 39:9-11.
Mah DY, Sherwin ED, Alexander ME, Cecchin F, Abrams DJ, Walsh EP, Triedman JK. The electrophysiological characteristics of accessory pathways in pediatric patients with intermittent preexcitation. Pacing Clin Electrophysiol 2013; 36:1117-1122.
Spar DS, Silver ES, Hordof AJ, Liberman L. Relation of the utility of exercise testing for risk assessment in pediatric patients with ventricular preexcitation to pathway location. Am J Cardiol 2012; 109:1011-1014.
Beckman KJ, Gallastegui JL, Bauman JL, Hariman RJ. The predictive value of electrophysiologic studies in untreated patients with Wolff-Parkinson-White syndrome. J Am Coll Cardiol 1990; 15:640-647.
Bunch TJ, May HT, Bair TL, Anderson JL, Crandall BG, Cutler MJ, Jacobs V, Mallender C, Muhlestein JB, Osborn JS, Weiss JP, Day JD. Long-term natural history of adult Wolff-Parkinson-White syndrome patients treated with and without catheter ablation. Circ Arrhythm Electrophysiol 2015; 8:1465-1471.
Cain N, Irving C, Webber S, Beerman L, Arora G. Natural history of Wolff-Parkinson-White syndrome diagnosed in childhood. Am J Cardiol 2013; 112:961-965.
Brugada J, Puigfel M, Mont L, Garcia-Bolao I, Figueiredo M, Matas M, Navarro-Lopez F. Radiofrequency ablation of anteroseptal, para-Hisian, and mid-septal accessory pathways using a simplified femoral approach. Pacing Clin Electrophysiol 1998; 21:735-741.
Calkins H, Yong P, Miller JM, Olshansky B, Carlson M, Saul JP, Huang SK, Liem LB, Klein LS, Moser SA, Bloch DA, Gillette P, Prystowsky E. Catheter ablation of accessory pathways, atrioventricular nodal reentrant tachycardia, and the atrioventricular junction: Final results of a prospective, multicenter clinical trial. The Atakr Multicenter Investigators Group. Circulation 1999; 99: 262-270.
Schaffer MS, Silka MJ, Ross BA, Kugler JD. Inadvertent atrioventricular block during radiofrequency catheter ablation. Results of the Pediatric Radiofrequency Ablation Registry. Pediatric Electrophysiology Society. Circulation 1996; 94:3214-3220.
Bravo L, Atienza F, Eidelman G, Avila P, Pelliza M, Castellanos E, Loughlin G, Datino T, Torrecilla EG, Almendral J, Sanchez PL, Arenal A, Martínez-Alzamora N, Fernandez-Avilés F. Safety and efficacy of cryoablation vs. radiofrequency ablation of septal accessory pathways: Systematic review of the literature and meta-analyses. Europace 2017; 20:1334-1342.
Al-Khatib SM, Arshad A, Balk EM, Das SR, Hsu JC, Joglar JA, Page RL. Risk stratification for arrhythmic events in patients with asymptomatic pre-excitation: A systematic review for the 2015 ACC/AHA/HRS guideline for the management of adult patients with supraventricular tachycardia: A report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society. J Am Coll Cardiol 2016; 67:1624-1638.
Dai C, Guo B, Li W, Xiao Y, Jin M, Han L, Dong J. The effect of ventricular preexcitation on ventricular wall motion and left ventricular systolic function. Europace 2018; 20:1175-1181.
Kohli U, Pumphrey KL, Ahmed A, Das S. Pre-excitation induced ventricular dysfunction and successful berlin heart explantation after accessory pathway ablation. J Electrocardiol 2018; 51:1067-1070.
Nagai T, Hamabe A, Arakawa J, Tabata H, Nishioka T. The impact of left ventricular deformation and dyssynchrony on improvement of left ventricular ejection fraction following radiofrequency catheter ablation in Wolff-Parkinson-White syndrome: A comprehensive study by speckle tracking echocardiography. Echocardiography 2017; 34:1610-1616.
Kwon EN, Carter KA, Kanter RJ. Radiofrequency catheter ablation for dyssynchrony-induced dilated cardiomyopathy in an infant. Congenit Heart Dis 2014; 9:E179-E184.
Telishevska M, Hebe J, Paul T, Nurnberg JH, Krause U, Gebauer R, Gass M, Balmer C, Berger F, Molatta S, Emmel M, Lawrenz W, Kriebel T, Hessling G. Catheter ablation in ASymptomatic PEDiatric patients with ventricular preexcitation: Results from the multicenter "CASPED" study. Clin Res Cardiol 2018; 108:683-690.
Marelli AJ, Ionescu-Ittu R, Mackie AS, Guo L, Dendukuri N, Kaouache M. Lifetime prevalence of congenital heart disease in the general population from 2000 to 2010. Circulation 2014; 130:749-756.
Hernandez-Madrid A, Paul T, Abrams D, Aziz PF, Blom NA, Chen J, Chessa M, Combes N, Dagres N, Diller G, Ernst S, Giamberti A, Hebe J, Janousek J, Kriebel T, Moltedo J, Moreno J, Peinado R, Pison L, Rosenthal E, Skinner JR, Zeppenfeld K; ESC Scientific Document Group. Arrhythmias in congenital heart disease: A position paper of the European Heart Rhythm Association (EHRA), Association for European Paediatric and Congenital Cardiology (AEPC), and the European Society of Cardiology (ESC) Working Group on Grown-up Congenital Heart Disease, endorsed by HRS, PACES, APHRS, and SOLAECE. Europace 2018; 20:1719-1753.
Moons P, Bovijn L, Budts W, Belmans A, Gewillig M. Temporal trends in survival to adulthood among patients born with congenital heart disease from 1970 to 1992 in Belgium. Circulation 2010; 122:2264-2272.
Avila P, Mercier LA, Dore A, Marcotte F, Mongeon FP, Ibrahim R, Asgar A, Miro J, Andelfinger G, Mondesert B, de Guise P, Poirier N, Khairy P. Adult congenital heart disease: A growing epidemic. Can J Cardiol 2014; 30:S410-S419.
Janson CM, Shah MJ. Supraventricular tachycardia in adult congenital heart disease: Mechanisms, diagnosis, and clinical aspects. Card Electrophysiol Clin 2017; 9:189-211.
Verheugt CL, Uiterwaal CS, van der Velde ET, Meijboom FJ, Pieper PG, Sieswerda GT, Plokker HW, Grobbee DE, Mulder BJ. The emerging burden of hospital admissions of adults with congenital heart disease. Heart 2010; 96:872-878.
Gallego P, Gonzalez AE, Sanchez-Recalde A, Peinado R, Polo L, Gomez-Rubin C, Lopez-Sendon JL, Oliver JM. Incidence and predictors of sudden cardiac arrest in adults with congenital heart defects repaired before adult life. Am J Cardiol 2012; 110:109-117.
Koyak Z, Harris L, de Groot JR, Silversides CK, Oechslin EN, Bouma BJ, Budts W, Zwinderman AH, Van Gelder IC, Mulder BJ. Sudden cardiac death in adult congenital heart disease. Circulation 2012; 126:1944-1954.
Lin JH, Kean AC, Cordes TM. The risk of thromboembolic complications in Fontan patients with atrial flutter/fibrillation treated with electrical cardioversion. Pediatr Cardiol 2016; 37:1351-1360.
Ammash NM, Phillips SD, Hodge DO, Connolly HM, Grogan MA, Friedman PA, Warnes CA, Asirvatham SJ. Outcome of direct current cardioversion for atrial arrhythmias in adults with congenital heart disease. Int J Cardiol 2012; 154:270-274.
Israel CW, Barold SS. Electrical storm in patients with an implanted defibrillator: A matter of definition. Ann Noninvasive Electrocardiol 2007; 12:375-382.
Sherman L, Niemann J, Youngquist ST, Shah AP, Rosborough JP. Beta-blockade causes a reduction in the frequency spectrum of VF but improves resuscitation outcome: A potential limitation of quantitative waveform measures. Resuscitation 2012; 83:511-516.
Khairy P, Clair M, Fernandes SM, Blume ED, Powell AJ, Newburger JW, Landzberg MJ, Mayer JE. Cardiovascular outcomes after the arterial switch operation for Dtransposition of the great arteries. Circulation 2013; 127:331-339.
Coughtrie AL, Behr ER, Layton D, Marshall V, Camm AJ, Shakir SAW. Drugs and life-threatening ventricular arrhythmia risk: Results from the DARE study cohort. BMJ Open 2017; 7:e016627.
Valentino MA, Panakos A, Ragupathi L, Williams J, Pavri BB. Flecainide toxicity: A case report and systematic review of its electrocardiographic patterns and management. Cardiovasc Toxicol 2017; 17:260-266.
Thorne SA, Barnes I, Cullinan P, Somerville J. Amiodarone-associated thyroid dysfunction. Risk factors in adults with congenital heart disease. Circulation 1999; 100:149-154.
Pujol C, Niesert A-C, Engelhardt A, Schoen P, Kusmenkov E, Pittrow D, Ewert P, Kaemmerer H. Usefulness of direct oral anticoagulants in adult congenital heart disease. Am J Cardiol 2016; 117:450-455.
Wu J, Deisenhofer I, Ammar S, Fichtner S, Reents T, Zhu P, Jilek C, Kolb C, Hess J, Hessling G. Acute and long-term outcome after catheter ablation of supraventricular tachycardia in patients after the Mustard or Senning operation for D-transposition of the great arteries. Europace 2013; 15:886-891.
Roten L, Lukac P, De Groot N, Cosedis Nielsen J, Szili-Torok T, Kjaerulf Jensen H, Zimmermann M, Delacrétaz E. Catheter ablation of arrhythmias in Ebstein's anomaly: A multicenter study. J Cardiovasc Electrophysiol 2011; 22:1391-1396.
Deal BJ, Mavroudis C. Arrhythmia surgery for adults with congenital heart disease. Card Electrophysiol Clin 2017; 9:329-340.
Shivapour JK, Sherwin ED, Alexander ME, Cecchin F, Mah DY, Triedman JK, Marx GR, del Nido PJ, Walsh EP. Utility of preoperative electrophysiologic studies in patients with Ebstein's anomaly undergoing the Cone procedure. Heart Rhythm 2014; 11:182-186.
Deal BJ, Mavroudis C, Backer CL, Buck SH, Johnsrude C. Comparison of anatomic isthmus block with the modified right atrial maze procedure for late atrial tachycardia in Fontan patients. Circulation 2002; 106:575-579.
Koyak Z, Kroon B, de Groot JR, Wagenaar LJ, van Dijk AP, Mulder BA, Van Gelder IC, Post MC, Mulder BJM, Bouma BJ. Efficacy of antiarrhythmic drugs in adults with congenital heart disease and supraventricular tachycardias. Am J Cardiol 2013; 112:1461-1467.
Combes N, Derval N, Hascoet S, Zhao A, Amet D, Le Bloa M, Maltret A, Heitz F, Thambo JB, Marijon E. Ablation of supraventricular arrhythmias in adult congenital heart disease: A contemporary review. Arch Cardiovasc Dis 2017; 110:334-345.
Dallaglio PD, Anguera I, Jiménez-Candil J, Peinado R, García-Seara J, Arcocha MF, Macías R, Herreros B, Quesada A, Hernandez-Madrid A, Alvarez M, Di Marco A, Filgueiras D, Matía R, Cequier A, Sabaté X. Impact of previous cardiac surgery on long-term outcome of cavotricuspid isthmus-dependent atrial flutter ablation. Europace 2016; 18:873-880.
Wasmer K, Köbe J, Dechering DG, Bittner A, Mönnig G, Milberg P, Baumgartner H, Breithardt G, Eckardt L. Isthmus-dependent right atrial flutter as the leading cause of atrial tachycardias after surgical atrial septal defect repair. Int J Cardiol 2013; 168:2447-2452.
Nie J-G, Dong J-Z, Salim M, Li S-N, Wu X-Y, Chen Y-W, Bai R, Liu N, Du X, Ma C-S. Catheter ablation of atrial fibrillation in patients with atrial septal defect: Long-term follow-up results. J Interv Card Electrophysiol 2015; 42:43-49.
Chauvaud SM, Brancaccio G, Carpentier AF. Cardiac arrhythmia in patients undergoing surgical repair of Ebstein's anomaly. Ann Thorac Surg 2001; 71:1547-1552.
Khairy P, Van Hare GF, Balaji S, Berul CI, Cecchin F, Cohen MI, Daniels CJ, Deal BJ, Dearani JA, Groot Nd, Dubin AM, Harris L, Janousek J, Kanter RJ, Karpawich PP, Perry JC, Seslar SP, Shah MJ, Silka MJ, Triedman JK, Walsh EP, Warnes CA. PACES/HRS Expert Consensus Statement on the Recognition and Management of Arrhythmias in Adult Congenital Heart Disease: Developed in partnership between the Pediatric and Congenital Electrophysiology Society (PACES) and the Heart Rhythm Society (HRS). Endorsed by the governing bodies of PACES, HRS, the American College of Cardiology (ACC), the American Heart Association (AHA), the European Heart Rhythm Association (EHRA), the Canadian Heart Rhythm Society (CHRS), and the International Society for Adult Congenital Heart Disease (ISACHD). Heart Rhythm 2014; 11:e102-e165.
Khositseth A, Danielson GK, Dearani JA, Munger TM, Porter CJ. Supraventricular tachyarrhythmias in Ebstein anomaly: Management and outcome. J Thorac Cardiovasc Surg 2004; 128:826-833.
Shivapour JKL, Sherwin ED, Alexander ME, Cecchin F, Mah DY, Triedman JK, Marx GR, del Nido PJ, Walsh EP. Utility of preoperative electrophysiologic studies in patients with Ebstein's anomaly undergoing the Cone procedure. Heart Rhythm 2014; 11:182-186.
Correa R, Walsh EP, Alexander ME, Mah DY, Cecchin F, Abrams DJ, Triedman JK. Transbaffle mapping and ablation for atrial tachycardias after mustard, senning, or Fontan operations. J Am Heart Assoc 2013; 2:e000325.
Krause U, Backhoff D, Klehs S, Schneider HE, Paul T. Transbaffle catheter ablation of atrial re-entrant tachycardia within the pulmonary venous atrium in adult patients with congenital heart disease. Europace 2016; 18:1055-1060.
Houck CA, Teuwen CP, Bogers AJ, de Groot NM. Atrial tachyarrhythmias after atrial switch operation for transposition of the great arteries: Treating old surgery with new catheters. Heart Rhythm 2016; 13:1731-1738.
Wu M-H, Lu C-W, Chen H-C, Chiu S-N, Kao F-Y, Huang S-K. Arrhythmic burdens in patients with tetralogy of Fallot: A national database study. Heart Rhythm 2015; 12:604-609.
de Groot NMS, Lukac P, Schalij MJ, Makowski K, Szili-Torok T, Jordaens L, Nielsen JC, Jensen HK, Gerdes JC, Delacretaz E. Long-term outcome of ablative therapy of post-operative atrial tachyarrhythmias in patients with tetralogy of Fallot: A European multi-centre study. Europace 2012; 14:522-527.
Weipert J, Noebauer C, Schreiber C, Kostolny M, Zrenner B, Wacker A, Hess J, Lange R. Occurrence and management of atrial arrhythmia after long-term Fontan circulation. J Thorac Cardiovasc Surg 2004; 127:457-464.
Mavroudis C, Deal BJ. Fontan conversion: Literature review and lessons learned over 20 years. World J Pediatr Congenit Heart Surg 2016; 7:192-198.
Stewart RD, Pasquali SK, Jacobs JP, Benjamin DK, Jaggers J, Cheng J, Mavroudis C, Jacobs ML. Contemporary Fontan operation: Association between early outcome and type of cavopulmonary connection. Ann Thorac Surg 2012; 93:1254-1260; discussion 1261.
Brugada J, Blom N, Sarquella-Brugada G, Blomstrom-Lundqvist C, Deanfield J, Janousek J, Abrams D, Bauersfeld U, Brugada R, Drago F, de Groot N, Happonen J-M, Hebe J, Yen Ho S, Marijon E, Paul T, Pfammatter J-P, Rosenthal E. Pharmacological and non-pharmacological therapy for arrhythmias in the pediatric population: EHRA and AEPC-Arrhythmia Working Group joint consensus statement. Europace 2013; 15:1337-1382.
Philip Saul J, Kanter RJ, Writing C, Abrams D, Asirvatham S, Bar-Cohen Y, Blaufox AD, Cannon B, Clark J, Dick M, Freter A, Kertesz NJ, Kirsh JA, Kugler J, LaPage M, McGowan FX, Miyake CY, Nathan A, Papagiannis J, Paul T, Pflaumer A, Skanes AC, Stevenson WG, Von Bergen N, Zimmerman F. PACES/HRS expert consensus statement on the use of catheter ablation in children and patients with congenital heart disease: Developed in partnership with the Pediatric and Congenital Electrophysiology Society (PACES) and the Heart Rhythm Society (HRS). Endorsed by the governing bodies of PACES, HRS, the American Academy of Pediatrics (AAP), the American Heart Association (AHA), and the Association for European Pediatric and Congenital Cardiology (AEPC). Heart Rhythm 2016; 13:e251-e289.
Perry JC, Garson A Jr. Supraventricular tachycardia due to Wolff-Parkinson-White syndrome in children: Early disappearance and late recurrence. J Am Coll Cardiol 1990; 16:1215-1220.
Bensler JM, Frank CM, Razavi M, Rasekh A, Saeed M, Haas PC, Nazeri A, Massumi A. Tachycardia-mediated cardiomyopathy and the permanent form of junctional reciprocating tachycardia. Tex Heart Inst J 2010; 37:695-698.
Ellis ER, Josephson ME. What about tachycardia-induced cardiomyopathy?. Arrhythm Electrophysiol Rev 2013; 2:82-90.
Richardson C, Silver ES. Management of supraventricular tachycardia in infants. Paediatr Drugs 2017; 19:539-551.
Lewis J, Arora G, Tudorascu DL, Hickey RW, Saladino RA, Manole MD. Acute management of refractory and unstable pediatric supraventricular tachycardia. J Pediatr 2017; 181:177-182.e2.
Saul JP, Hulse JE, Papagiannis J, Van Praagh R, Walsh EP. Late enlargement of radiofrequency lesions in infant lambs. Implications for ablation procedures in small children. Circulation 1994; 90:492-499.
Femenía F, Sarquella-Brugada G, Brugada J. Single-catheter radiofrequency ablation of a permanent junctional reciprocating tachycardia in a premature neonate. Cardiol Young 2012; 22:606-609.
Hinkle KA, Peyvandi S, Stiver C, Killen SAS, Weng HY, Etheridge SP, Puchalski MD. Postnatal outcomes of fetal supraventricular tachycardia: A multicenter study. Pediatr Cardiol 2017; 38:1317-1323.
Fouron J-C, Fournier A, Proulx F, Lamarche J, Bigras JL, Boutin C, Brassard M, Gamache S. Management of fetal tachyarrhythmia based on superior vena cava/aorta Doppler flow recordings. Heart 2003; 89:1211-1216.
Jaeggi ET, Carvalho JS, De Groot E, Api O, Clur S-AB, Rammeloo L, McCrindle BW, Ryan G, Manlhiot C, Blom NA. Comparison of transplacental treatment of fetal supraventricular tachyarrhythmias with digoxin, flecainide, and sotalol: Results of a nonrandomized multicenter study. Circulation 2011; 124:1747-1754.
Price JF, Kertesz NJ, Snyder CS, Friedman RA, Fenrich AL. Flecainide and sotalol: A new combination therapy for refractory supraventricular tachycardia in children <1 year of age. J Am Coll Cardiol 2002; 39:517-20.
Vaidya VR, Arora S, Patel N, Badheka AO, Patel N, Agnihotri K, Billimoria Z, Turakhia MP, Friedman PA, Madhavan M, Kapa S, Noseworthy PA, Cha Y-M, Gersh B, Asirvatham SJ, Deshmukh AJ. Burden of arrhythmia in pregnancy. Circulation 2017; 135:619-621.
Opotowsky AR, Siddiqi OK, D'Souza B, Webb GD, Fernandes SM, Landzberg MJ. Maternal cardiovascular events during childbirth among women with congenital heart disease. Heart 2012; 98:145-151.
Silversides CK, Harris L, Haberer K, Sermer M, Colman JM, Siu SC. Recurrence rates of arrhythmias during pregnancy in women with previous tachyarrhythmia and impact on fetal and neonatal outcomes. Am J Cardiol 2006; 97: 1206-1212.
Lee SH, Chen SA, Wu TJ, Chiang CE, Cheng CC, Tai CT, Chiou CW, Ueng KC, Chang MS. Effects of pregnancy on first onset and symptoms of paroxysmal supraventricular tachycardia. Am J Cardiol 1995; 76:675-678.
Moore JS, Teefey P, Rao K, Berlowitz MS, Chae SH, Yankowitz J. Maternal arrhythmia: A case report and review of the literature. Obstet Gynecol Surv 2012; 67:298-312.
Wang YC, Chen CH, Su HY, Yu MH. The impact of maternal cardioversion on fetal haemodynamics. Eur J Obstet Gynecol Reprod Biol 2006; 126:268-269.
Elkayam U, Goodwin TM. Adenosine therapy for supraventricular tachycardia during pregnancy. Am J Cardiol 1995; 75:521-523.
Ghosh N, Luk A, Derzko C, Dorian P, Chow CM. The acute treatment of maternal supraventricular tachycardias during pregnancy: A review of the literature. J Obstet Gynaecol Can 2011; 33:17-23.
Halpern DG, Weinberg CR, Pinnelas R, Mehta-Lee S, Economy KE, Valente AM. Use of medication for cardiovascular disease during pregnancy: JACC State-of-the-Art Review. J Am Coll Cardiol 2019; 73:457-476.
Kockova R, Kocka V, Kiernan T, Fahy GJ. Ibutilide-induced cardioversion of atrial fibrillation during pregnancy. J Cardiovasc Electrophysiol 2007; 18:545-547.
Burkart TA, Kron J, Miles WM, Conti JB, Gonzalez MD. Successful termination of atrial flutter by ibutilide during pregnancy. Pacing Clin Electrophysiol 2007; 30:283-286.
Liu YL, Nwosu UC, Rice PJ. Relaxation of isolated human myometrial muscle by beta2-adrenergic receptors but not beta1-adrenergic receptors. Am J Obstet Gynecol 1998; 179:895-898.
Tanaka K, Tanaka H, Kamiya C, Katsuragi S, Sawada M, Tsuritani M, Yoshida M, Iwanaga N, Yoshimatsu J, Ikeda T. Beta-blockers and fetal growth restriction in pregnant women with cardiovascular disease. Circ J 2016; 80:2221-2226.
Bateman BT, Heide-Jorgensen U, Einarsdottir K, Engeland A, Furu K, Gissler M, Hernandez-Diaz S, Kieler H, Lahesmaa-Korpinen AM, Mogun H, Norgaard M, Reutfors J, Selmer R, Huybrechts KF, Zoega H. Beta-blocker use in pregnancy and the risk for congenital malformations: An international cohort study. Ann Intern Med 2018; 169:665-673.
Jaeggi ET, Carvalho JS, De Groot E, Api O, Clur SA, Rammeloo L, McCrindle BW, Ryan G, Manlhiot C, Blom NA. Comparison of transplacental treatment of fetal supraventricular tachyarrhythmias with digoxin, flecainide, and sotalol: Results of a nonrandomized multicenter study. Circulation 2011; 124:1747-1754.
Driver K, Chisholm CA, Darby AE, Malhotra R, Dimarco JP, Ferguson JD. Catheter ablation of arrhythmia during pregnancy. J Cardiovasc Electrophysiol 2015; 26:698-702.
Chen G, Sun G, Xu R, Chen X, Yang L, Bai Y, Yang S, Guo P, Zhang Y, Zhao C, Wang DW, Wang Y. Zero-fluoroscopy catheter ablation of severe drug-resistant arrhythmia guided by Ensite NavX system during pregnancy: Two case reports and literature review. Medicine (Baltimore) 2016; 95:e4487.
Szumowski L, Szufladowicz E, Orczykowski M, Bodalski R, Derejko P, Przybylski A, Urbanek P, Kusmierczyk M, Kozluk E, Sacher F, Sanders P, Dangel J, Haissaguerre M, Walczak F. Ablation of severe drug-resistant tachyarrhythmia during pregnancy. J Cardiovasc Electrophysiol 2010; 21:877-882.
Duan L, Ng A, Chen W, Spencer HT, Nguyen J, Shen AY, Lee MS. Beta-blocker exposure in pregnancy and risk of fetal cardiac anomalies. JAMA Intern Med 2017; 177:885-887.
Duan L, Ng A, Chen W, Spencer HT, Lee MS. Beta-blocker subtypes and risk of low birth weight in newborns. J Clin Hypertens (Greenwich) 2018; 20:1603-1609.
Bergman JEH, Lutke LR, Gans ROB, Addor MC, Barisic I, Cavero-Carbonell C, Garne E, Gatt M, Klungsoyr K, Lelong N, Lynch C, Mokoroa O, Nelen V, Neville AJ, Pierini A, Randrianaivo H, Rissmann A, Tucker D, Wiesel A, Dolk H, Loane M, Bakker MK. Beta-blocker use in pregnancy and risk of specific congenital anomalies: A European case-malformed control study. Drug Saf 2018; 41:415-427.
Razminia M, Willoughby MC, Demo H, Keshmiri H, Wang T, D'Silva OJ, Zheutlin TA, Jibawi H, Okhumale P, Kehoe RF. Fluoroless catheter ablation of cardiac arrhythmias: A 5-year experience. Pacing Clin Electrophysiol 2017; 40:425-433.
Lishmanov A, Chockalingam P, Senthilkumar A, Chockalingam A. Tachycardiainduced cardiomyopathy: Evaluation and therapeutic options. Congest Heart Fail 2010; 16:122-126.
Nerheim P, Birger-Botkin S, Piracha L, Olshansky B. Heart failure and sudden death in patients with tachycardia-induced cardiomyopathy and recurrent tachycardia. Circulation 2004; 110:247-252.
Shinbane JS, Wood MA, Jensen DN, Ellenbogen KA, Fitzpatrick AP, Scheinman MM. Tachycardia-induced cardiomyopathy: A review of animal models and clinical studies. J Am Coll Cardiol 1997; 29:709-715.
Ellis ER, Josephson ME. Heart failure and tachycardia-induced cardiomyopathy. Curr Heart Fail Rep 2013; 10:296-306.
Gopinathannair R, Etheridge SP, Marchlinski FE, Spinale FG, Lakkireddy D, Olshansky B. Arrhythmia-induced cardiomyopathies: Mechanisms, recognition, and management. J Am Coll Cardiol 2015; 66:1714-1728.
Callans DJ. Premature ventricular contraction-induced cardiomyopathy. Arrhythm Electrophysiol Rev 2017; 6:153-155.
Clementy N, Casset-Senon D, Giraudeau C, Cosnay P. Tachycardiomyopathy secondary to nonreentrant atrioventricular nodal tachycardia: Recovery after slow pathway ablation. Pacing Clin Electrophysiol 2007; 30:925-928.
Gopinathannair R, Sullivan RM, Olshansky B. Tachycardia-mediated cardiomyopathy: Recognition and management. Curr Heart Fail Rep 2009; 6:257-264.
Mueller KAL, Heinzmann D, Klingel K, Fallier-Becker P, Kandolf R, Kilias A, Walker-Allgaier B, Borst O, Kumbrink J, Kirchner T, Langer H, Geisler T, Schreieck J, Gramlich M, Gawaz M, Seizer P. Histopathological and immunological characteristics of tachycardia-induced cardiomyopathy. J Am Coll Cardiol 2017; 69:2160-2172.
Cha Y-M, Lee GK, Klarich KW, Grogan M. Premature ventricular contractioninduced cardiomyopathy. A treatable condition. Circ Arrhythm Electrophysiol 2012; 5:229-236.
Kotecha D, Flather MD, Altman DG, Holmes J, Rosano G, Wikstrand J, Packer M, Coats AJS, Manzano L, Böhm M, van Veldhuisen DJ, Andersson B, Wedel H, von Lueder TG, Rigby AS, Hjalmarson A, Kjekshus J, Cleland JGF. Heart rate and rhythm and the benefit of beta-blockers in patients with heart failure. J Am Coll Cardiol 2017; 69:2885-2896.
Sadron Blaye-Felice M, Hamon D, Sacher F, Pascale P, Rollin A, Duparc A, Mondoly P, Derval N, Denis A, Cardin C, Hocini M, Jaïs P, Schlaepfer J, Bongard V, Carrié D, Galinier M, Pruvot E, Lellouche N, Haïssaguerre M, Maury P. Premature ventricular contraction-induced cardiomyopathy: Related clinical and electrophysiologic parameters. Heart Rhythm 2016; 13:103-110.
Sohinki D, Ho J, Srinivasan N, Collins LJ, Obel OA. Outcomes after atrioventricular node ablation and biventricular pacing in patients with refractory atrial fibrillation and heart failure: A comparison between non-ischaemic and ischaemic cardiomyopathy. Europace 2014; 16:880-886.
Stavrakis S, Garabelli P, Reynolds DW. Cardiac resynchronization therapy after atrioventricular junction ablation for symptomatic atrial fibrillation: A meta-analysis. Europace 2012; 14:1490-1497.
Brignole M, Botto G, Mont L, Iacopino S, De Marchi G, Oddone D, Luzi M, Tolosana JM, Navazio A, Menozzi C. Cardiac resynchronization therapy in patients undergoing atrioventricular junction ablation for permanent atrial fibrillation: A randomized trial. Eur Heart J 2011; 32:2420-2429.
Huang W, Su L, Wu S, Xu L, Xiao F, Zhou X, Ellenbogen KA. Benefits of permanent His bundle pacing combined with atrioventricular node ablation in atrial fibrillation patients with heart failure with both preserved and reduced left ventricular ejection fraction. J Am Heart Assoc 2017; 6:e005309.
Pelliccia A, Fagard R, Bjørnstad HH, Anastassakis A, Arbustini E, Assanelli D, Biffi A, Borjesson M, Carrè F, Corrado D, Delise P, Dorwarth U, Hirth A, Heidbuchel H, Hoffmann E, Mellwig KP, Panhuyzen-Goedkoop N, Pisani A, Solberg EE, van-Buuren F, Vanhees L, Blomstrom-Lundqvist C, Deligiannis A, Dugmore D, Glikson M, Hoff PI, Hoffmann A, Hoffmann E, Horstkotte D, Nordrehaug JE, Oudhof J, McKenna WJ, Penco M, Priori S, Reybrouck T, Senden J, Spataro A, Thiene G; Study Group of Sports Cardiology of the Working Group of Cardiac Rehabilitation and Exercise Physiology; Working Group of Myocardial and Pericardial Diseases of the European Society of Cardiology. Recommendations for competitive sports participation in athletes with cardiovascular disease: A consensus document from the Study Group of Sports Cardiology of the Working Group of Cardiac Rehabilitation and Exercise Physiology and the Working Group of Myocardial and Pericardial Diseases of the European Society of Cardiology. Eur Heart J 2005; 26:1422-1445.
Heidbüchel H, Panhuyzen-Goedkoop N, Corrado D, Hoffmann E, Biffi A, Delise P, Blomstrom-Lundqvist C, Vanhees L, Hoff PI, Dorwarth U, Pelliccia A; Study Group on Sports Cardiology of the European Association for Cardiovascular Prevention and Rehabilitation. Recommendations for participation in leisure-time physical activity and competitive sports in patients with arrhythmias and potentially arrhythmogenic conditions Part I: Supraventricular arrhythmias and pacemakers. Eur J Cardiovasc Prev Rehabil 2006; 13:475-484.
Rao AL, Salerno JC, Asif IM, Drezner JA. Evaluation and management of Wolff-Parkinson-White in athletes. Sports health: A multidisciplinary approach 2014; 6:326-332.
Abdulla J, Nielsen JR. Is the risk of atrial fibrillation higher in athletes than in the general population?. A systematic review and meta-analysis. Europace 2009; 11:1156-1159.
Heidbüchel H, Panhuyzen-Goedkoop N, Corrado D, Hoffmann E, Biffi A, Delise P, Blomstrom-Lundqvist C, Vanhees L, Ivarhoff P, Dorwarth U, Pelliccia A; Study Group on Sports Cardiology of the European Association for Cardiovascular Prevention and Rehabilitation. Recommendations for participation in leisure-time physical activity and competitive sports in patients with arrhythmias and potentially arrhythmogenic conditions Part I: Supraventricular arrhythmias and pacemakers. Eur J Cardiovasc Prev Rehabil 2006; 13:475-484.
Heidbüchel H, Corrado D, Biffi A, Hoffmann E, Panhuyzen-Goedkoop N, Hoogsteen J, Delise P, Hoff PI, Pelliccia A; Study Group on Sports Cardiology of the European Association for Cardiovascular Prevention and Rehabilitation. Recommendations for participation in leisure-time physical activity and competitive sports of patients with arrhythmias and potentially arrhythmogenic conditions. Part II: Ventricular arrhythmias, channelopathies and implantable defibrillators. Eur J Cardiovasc Prev Rehabil 2006; 13:676-686.
Katritsis D, Anderson A, Webb-Peploe MM. Regulations concerning individual risk and public safety. ESC Textbook of Cardiology 2018.
European Working Group on Driving and Cardiovascular Disease. New standards for driving and cardiovascular diseases. Report of the Expert Group on Driving and Cardiovascular Disease. https://ec.europa.eu/transport/road-safety/sites/roadsafety/files/pdf/behavior/driving-and-cardiovascular-disease-final.pdf (date accessed May 2019).
Nakagawa H, Natale A. Catheter ablation of complex tachyarrhythmias using remote magnetic catheter navigation system. J Cardiovasc Electrophysiol 2016; 27:S3-S4.
Hilbert S, Sommer P, Gutberlet M, Gaspar T, Foldyna B, Piorkowski C, Weiss S, Lloyd T, Schnackenburg B, Krueger S, Fleiter C, Paetsch I, Jahnke C, Hindricks G, Grothoff M. Real-time magnetic resonance-guided ablation of typical right atrial flutter using a combination of active catheter tracking and passive catheter visualization in man: Initial results from a consecutive patient series. Europace 2016; 18:572-577.
Perlman O, Katz A, Amit G, Zigel Y. Supraventricular tachycardia classification in the 12-lead ECG using atrial waves detection and a clinically based tree scheme. IEEE J Biomed Health Inform 2016; 20:1513-1520.
Katritsis G, Luther V, Kanagaratnam P, Linton NW. Arrhythmia mechanisms revealed by ripple mapping. Arrhythm Electrophysiol Rev 2018; 7:261-264.
Luther V, Cortez-Dias N, Carpinteiro L, de Sousa J, Balasubramaniam R, Agarwal S, Farwell D, Sopher M, Babu G, Till R, Jones N, Tan S, Chow A, Lowe M, Lane J, Pappachan N, Linton N, Kanagaratnam P. Ripple mapping: Initial multicenter experience of an intuitive approach to overcoming the limitations of 3D activation mapping. J Cardiovasc Electrophysiol 2017; 28:1285-1294.
Latcu DG, Bun SS, Viera F, Delassi T, El Jamili M, Al Amoura A, Saoudi N. Selection of critical isthmus in scar-related atrial tachycardia using a new automated ultrahigh resolution mapping system. Circ Arrhythm Electrophysiol 2017; 10:e004510.
Walsh KA, Galvin J, Keaney J, Keelan E, Szeplaki G. First experience with zero-fluoroscopic ablation for supraventricular tachycardias using a novel impedance and magnetic-field-based mapping system. Clin Res Cardiol 2018; 107:578-585.
Luther V, Linton NW, Koa-Wing M, Lim PB, Jamil-Copley S, Qureshi N, Ng FS, Hayat S, Whinnett Z, Davies DW, Peters NS, Kanagaratnam P. A prospective study of ripple mapping in atrial tachycardias: A novel approach to interpreting activation in low-voltage areas. Circ Arrhythm Electrophysiol 2016; 9:e003582.
Anter E, McElderry TH, Contreras-Valdes FM, Li J, Tung P, Leshem E, Haffajee CI, Nakagawa H, Josephson ME. Evaluation of a novel high-resolution mapping technology for ablation of recurrent scar-related atrial tachycardias. Heart Rhythm 2016; 13:2048-2055.
Gollob MH, Green MS, Tang AS-L, Gollob T, Karibe A, Hassan A-S, Ahmad F, Lozado R, Shah G, Fananapazir L, Bachinski LL, Tapscott T, Gonzales O, Begley D, Mohiddin S, Roberts R. Identification of a gene responsible for familial Wolff-Parkinson-White syndrome. N Engl J Med 2001; 344:1823-1831.
Wolf CM, Arad M, Ahmad F, Sanbe A, Bernstein SA, Toka O, Konno T, Morley G, Robbins J, Seidman JG, Seidman CE, Berul CI. Reversibility of PRKAG2 glycogen-storage cardiomyopathy and electrophysiological manifestations. Circulation 2008; 117:144-154.
Tan HL, van der Wal AC, Campian ME, Kruyswijk HH, ten Hove Jansen B, van Doorn D-J, Oskam HJ, Becker AE, Wilde AAM. Nodoventricular accessory pathways in PRKAG2-dependent familial preexcitation syndrome reveal a disorder in cardiac development. Circ Arrhythm Electrophysiol 2008; 1:276-281.
Lalani SR, Thakuria JV, Cox GF, Wang X, Bi W, Bray MS, Shaw C, Cheung SW, Chinault AC, Boggs BA, Ou Z, Brundage EK, Lupski JR, Gentile J, Waisbren S, Pursley A, Ma L, Khajavi M, Zapata G, Friedman R, Kim JJ, Towbin JA, Stankiewicz P, Schnittger S, Hansmann I, Ai T, Sood S, Wehrens XH, Martin JF, Belmont JW, Potocki L. 20p12.3 microdeletion predisposes to Wolff-Parkinson-White syndrome with variable neurocognitive deficits. J Med Genet 2009; 46:168-175.
Sidhu JS, Rajawat YS, Rami TG, Gollob MH, Wang Z, Yuan R, Marian AJ, DeMayo FJ, Weilbacher D, Taffet GE, Davies JK, Carling D, Khoury DS, Roberts R. Transgenic mouse model of ventricular preexcitation and atrioventricular reentrant tachycardia induced by an AMP-activated protein kinase loss-of-function mutation responsible for Wolff-Parkinson-White syndrome. Circulation 2005; 111:21-29.
Hasdemir C, Payzin S, Kocabas U, Sahin H, Yildirim N, Alp A, Aydin M, Pfeiffer R, Burashnikov E, Wu Y, Antzelevitch C. High prevalence of concealed Brugada syndrome in patients with atrioventricular nodal reentrant tachycardia. Heart Rhythm 2015; 12:1584-1594.
Weyhrauch DL, Ye D, Boczek NJ, Tester DJ, Gavrilova RH, Patterson MC, Wieben ED, Ackerman MJ. Whole exome sequencing and heterologous cellular electrophysiology studies elucidate a novel loss-of-function mutation in the CACNA1A-encoded neuronal P/Q-type calcium channel in a child with congenital hypotonia and developmental delay. Pediatr Neurol 2016; 55:46-51.
Baruscotti M, Bianco E, Bucchi A, DiFrancesco D. Current understanding of the pathophysiological mechanisms responsible for inappropriate sinus tachycardia: Role of the If "funny" current. J Interv Card Electrophysiol 2016; 46:19-28.
Josephson ME. Electrophysiology at a crossroads. Heart Rhythm 2007; 4: 658-661.